1
|
Monov G, Stein H, Klock L, Gallinat J, Kühn S, Murphy P, Donner T. P-116 Cortical dynamics of working memory maintenance in human aging. Clin Neurophysiol 2023. [DOI: 10.1016/j.clinph.2023.02.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/08/2023]
|
2
|
Gleich T, Spitta G, Butler O, Zacharias K, Aydin S, Sebold M, Garbusow M, Rapp M, Schubert F, Buchert R, Heinz A, Gallinat J. Dopamine D2/3 receptor availability in alcohol use disorder and individuals at high risk: Towards a dimensional approach. Addict Biol 2021; 26:e12915. [PMID: 32500613 DOI: 10.1111/adb.12915] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2019] [Revised: 04/09/2020] [Accepted: 04/17/2020] [Indexed: 12/14/2022]
Abstract
Alcohol use disorder (AUD) is the most common substance use disorder worldwide. Although dopamine-related findings were often observed in AUD, associated neurobiological mechanisms are still poorly understood. Therefore, in the present study, we investigate D2/3 receptor availability in healthy participants, participants at high risk (HR) to develop addiction (not diagnosed with AUD), and AUD patients in a detoxified stage, applying 18 F-fallypride positron emission tomography (18 F-PET). Specifically, D2/3 receptor availability was investigated in (1) 19 low-risk (LR) controls, (2) 19 HR participants, and (3) 20 AUD patients after alcohol detoxification. Quality and severity of addiction were assessed with clinical questionnaires and (neuro)psychological tests. PET data were corrected for age of participants and smoking status. In the dorsal striatum, we observed significant reductions of D2/3 receptor availability in AUD patients compared with LR participants. Further, receptor availability in HR participants was observed to be intermediate between LR and AUD groups (linearly decreasing). Still, in direct comparison, no group difference was observed between LR and HR groups or between HR and AUD groups. Further, the score of the Alcohol Dependence Scale (ADS) was inversely correlated with D2/3 receptor availability in the combined sample. Thus, in line with a dimensional approach, striatal D2/3 receptor availability showed a linear decrease from LR participants to HR participants to AUD patients, which was paralleled by clinical measures. Our study shows that a core neurobiological feature in AUD seems to be detectable in an early, subclinical state, allowing more individualized alcohol prevention programs in the future.
Collapse
Affiliation(s)
- Tobias Gleich
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
| | - Gianna Spitta
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
| | - Oisin Butler
- Max Planck Institute for Human Development Center for Lifespan Psychology Berlin Germany
| | - Kristin Zacharias
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
| | - Semiha Aydin
- Physikalisch‐Technische Bundesanstalt (PTB) Berlin Germany
| | - Miriam Sebold
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
- Department for Social and Preventive Medicine University of Potsdam Potsdam Germany
| | - Maria Garbusow
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
| | - Michael Rapp
- Max Planck Institute for Human Development Center for Lifespan Psychology Berlin Germany
| | | | - Ralph Buchert
- Department of Diagnostic and Interventional Radiology and Nuclear Medicine University Medical Center Hamburg‐Eppendorf Hamburg Germany
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité Campus Mitte (CCM) Charité – Universitätsmedizin Berlin Berlin Germany
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany
| |
Collapse
|
3
|
Strauß M, Petroff D, Huang J, Ulke C, Paucke M, Bogatsch H, Böhme P, Hoffmann K, Reif A, Kittel-Schneider S, Heuser I, Ahlers E, Gallinat J, Schöttle D, Fallgatter A, Ethofer T, Unterecker S, Hegerl U. The "VIP-ADHD trial": Does brain arousal have prognostic value for predicting response to psychostimulants in adult ADHD patients? Eur Neuropsychopharmacol 2021; 43:116-128. [PMID: 33388218 DOI: 10.1016/j.euroneuro.2020.12.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Revised: 12/10/2020] [Accepted: 12/15/2020] [Indexed: 11/16/2022]
Abstract
EEG studies have shown that adult ADHD patients have less stable brain arousal regulation than age and gender matched controls. Psychostimulants have brain arousal stabilising properties evident in EEG patterns. The aim of this study was to investigate whether the stability of brain arousal regulation has prognostic value in predicting response to methylphenidate therapy in adult ADHD patients. In an open-label, single-arm, multi-centre, confirmatory trial, 121 adult ADHD patients were recruited and 112 qualified for the full analysis set. All participants received an initial dose of 20 mg extended release methylphenidate at baseline. After a titration phase of up to 4 weeks, patients remained on a weight-based target dose of extended release methylphenidate for 4 weeks. Using the Vigilance Algorithm Leipzig (VIGALL 2.1), we assessed brain arousal regulation before the treatment with methylphenidate, based on a 15-min EEG at quiet rest recorded at baseline. Using automatic stage-classification of 1 s segments, we computed the mean EEG-vigilance (indexing arousal level) and an arousal stability score (indexing arousal regulation). The primary endpoint was the association between successful therapy, defined by a 30% reduction in CAARS, and stable/unstable brain arousal. 52 patients (46%) showed an unstable brain arousal regulation of which 23% had therapy success. In the stable group, 35% had therapy success, implying an absolute difference of 12 percentage points (95% CI -5 to 29, p = 0.17) in the direction opposite to the hypothesized one. There were no new findings regarding the tolerability and safety of extended release methylphenidate therapy.
Collapse
Affiliation(s)
- Maria Strauß
- Department of Psychiatry and Psychotherapy, University Hospital of Leipzig, Semmelweisstrasse 10, 04103 Leipzig, Germany.
| | - David Petroff
- Clinical Trial Centre Leipzig, Faculty of Medicine, University of Leipzig, Germany
| | - Jue Huang
- Department of Psychiatry and Psychotherapy, University Hospital of Leipzig, Semmelweisstrasse 10, 04103 Leipzig, Germany
| | - Christine Ulke
- Department of Psychiatry and Psychotherapy, University Hospital of Leipzig, Semmelweisstrasse 10, 04103 Leipzig, Germany
| | - Madlen Paucke
- Department of Psychiatry and Psychotherapy, University Hospital of Leipzig, Semmelweisstrasse 10, 04103 Leipzig, Germany
| | - Holger Bogatsch
- Clinical Trial Centre Leipzig, Faculty of Medicine, University of Leipzig, Germany
| | - Pierre Böhme
- Department of Psychiatry and Psychotherapy, University Hospital of Bochum, Germany
| | - Knut Hoffmann
- Department of Psychiatry and Psychotherapy, University Hospital of Bochum, Germany
| | - Andreas Reif
- Department of Psychiatry, Psychotherapy and Psychosomatic, University Hospital of Frankfurt
| | - Sarah Kittel-Schneider
- Department of Psychiatry, Psychotherapy and Psychosomatic, University Hospital of Frankfurt; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Würzburg, Germany
| | - Isabella Heuser
- Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Germany
| | - Eike Ahlers
- Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Germany
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Germany
| | - Daniel Schöttle
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Germany
| | - Andreas Fallgatter
- Department of Psychiatry and Psychotherapy, LEAD Graduate School and Research Network, University Hospital of Tübingen, Tübingen, Germany
| | - Thomas Ethofer
- Department of Psychiatry and Psychotherapy, LEAD Graduate School and Research Network, University Hospital of Tübingen, Tübingen, Germany; Department of Biomedical Magnetic Resonance, University Hospital of Tübingen, Germany
| | - Stefan Unterecker
- Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Würzburg, Germany
| | - Ulrich Hegerl
- Department of Psychiatry, Psychotherapy and Psychosomatic, University Hospital of Frankfurt
| |
Collapse
|
4
|
Montag C, Brandt L, Lehmann A, De Millas W, Falkai P, Gaebel W, Hasan A, Hellmich M, Janssen B, Juckel G, Karow A, Klosterkötter J, Lambert M, Maier W, Müller H, Pützfeld V, Schneider F, Stützer H, Wobrock T, Vernaleken IB, Wagner M, Heinz A, Bechdolf A, Gallinat J. Cognitive and emotional empathy in individuals at clinical high risk of psychosis. Acta Psychiatr Scand 2020; 142:40-51. [PMID: 32339254 DOI: 10.1111/acps.13178] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/22/2020] [Indexed: 01/07/2023]
Abstract
BACKGROUND Impairments of social cognition are considered core features of schizophrenia and are established predictors of social functioning. However, affective aspects of social cognition including empathy have far less been studied than its cognitive dimensions. The role of empathy in the development of schizophrenia remains largely elusive. METHODS Emotional and cognitive empathy were investigated in large sample of 120 individuals at Clinical High Risk of Psychosis (CHR-P) and compared with 50 patients with schizophrenia and 50 healthy controls. A behavioral empathy assessment, the Multifaceted Empathy Test, was implemented, and associations of empathy with cognition, social functioning, and symptoms were determined. RESULTS Our findings demonstrated significant reductions of emotional empathy in individuals at CHR-P, while cognitive empathy appeared intact. Only individuals with schizophrenia showed significantly reduced scores of cognitive empathy compared to healthy controls and individuals at CHR-P. Individuals at CHR-P were characterized by significantly lower scores of emotional empathy and unspecific arousal for both positive and negative affective valences compared to matched healthy controls and patients with schizophrenia. Results also indicated a correlation of lower scores of emotional empathy and arousal with higher scores of prodromal symptoms. CONCLUSION Findings suggest that the tendency to 'feel with' an interaction partner is reduced in individuals at CHR-P. Altered emotional reactivity may represent an additional, early vulnerability marker, even if cognitive mentalizing is grossly unimpaired in the prodromal stage. Different mechanisms might contribute to reductions of cognitive and emotional empathy in different stages of non-affective psychotic disorders and should be further explored.
Collapse
Affiliation(s)
- C Montag
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany
| | - L Brandt
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany
| | - A Lehmann
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany
| | - W De Millas
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Vivantes Wenckebach-Klinikum, Berlin, Germany
| | - P Falkai
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
| | - W Gaebel
- Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany
| | - A Hasan
- Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany
| | - M Hellmich
- Department of Psychiatry and Psychotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.,Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - B Janssen
- Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.,LVR-Klinik Langenfeld, Langenfeld, Germany
| | - G Juckel
- Department of Psychiatry, Psychotherapy, and Preventive Medicine, Ruhr University Bochum, Bochum, Germany
| | - A Karow
- Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - J Klosterkötter
- Department of Psychiatry and Psychotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - M Lambert
- Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - W Maier
- Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.,Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany.,DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany
| | - H Müller
- Department of Psychiatry and Psychotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - V Pützfeld
- Department of Psychiatry and Psychotherapy, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - F Schneider
- Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.,Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen, Aachen, Germany
| | - H Stützer
- Institute of Medical Statistics and Computational Biology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - T Wobrock
- Department of Psychiatry and Psychotherapy, Georg-August-University Goettingen, Goettingen, Germany.,Department of Psychiatry and Psychotherapy, County Hospitals Darmstadt-Dieburg, Groß-Umstadt, Germany
| | - I B Vernaleken
- Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen, Aachen, Germany
| | - M Wagner
- Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.,Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn, Bonn, Germany.,DZNE, German Center for Neurodegenerative Diseases, Bonn, Germany
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Germany
| | - A Bechdolf
- Department of Psychiatry, Psychotherapy, and Psychosomatics, Vivantes Klinikum am Urban and Vivantes Klinikum im Friedrichshain, Berlin, Germany.,Faculty of Medicine, University Hospital Cologne, Cologne, Germany.,ORYGEN, The National Centre of Excellence in Youth Mental Health, University of Melbourne, Melbourne, Australia
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
5
|
Galinowski A, Miranda R, Lemaitre H, Artiges E, Paillère Martinot M, Filippi I, Penttilä J, Grimmer Y, Noort BM, Stringaris A, Becker A, Isensee C, Struve M, Fadai T, Kappel V, Goodman R, Banaschewski T, Bokde AL, Bromberg U, Brühl R, Büchel C, Cattrell A, Conrod P, Desrivières S, Flor H, Fröhner JH, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Hohmann S, Jurk S, Millenet S, Nees F, Papadopoulos‐Orfanos D, Poustka L, Quinlan EB, Smolka MN, Walter H, Whelan R, Schumann G, Martinot J. Heavy drinking in adolescents is associated with change in brainstem microstructure and reward sensitivity. Addict Biol 2020; 25:e12781. [PMID: 31328396 DOI: 10.1111/adb.12781] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2018] [Revised: 03/31/2019] [Accepted: 05/02/2019] [Indexed: 11/30/2022]
Abstract
Heavy drinker adolescents: altered brainstem microstructure.
Collapse
Affiliation(s)
- André Galinowski
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
| | - Ruben Miranda
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
- Department of Psychiatry and AddictologyPaul Brousse Hospital Villejuif France
| | - Hervé Lemaitre
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
| | - Eric Artiges
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
- Center for Neuroimaging Research (CENIR)Brain & Spine Institute Paris France
- Psychiatry Department 91G16Orsay Hospital Orsay France
| | - Marie‐Laure Paillère Martinot
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
- Department of Child and Adolescent PsychiatryPitié‐Salpêtrière Hospital Paris France
| | - Irina Filippi
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
| | - Jani Penttilä
- Department of Social and Health CarePsychosocial Services Adolescent Outpatient Clinic Lahti Finland
| | - Yvonne Grimmer
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Betteke M. Noort
- Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus Charité MitteCharité‐Universitätsmedizin Berlin Berlin Germany
| | - Argyris Stringaris
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Andreas Becker
- Department of Child and Adolescent Psychiatry and PsychotherapyUniversity Medical Centre Göttingen Göttingen Germany
| | - Corinna Isensee
- Department of Child and Adolescent Psychiatry and PsychotherapyUniversity Medical Centre Göttingen Göttingen Germany
| | - Maren Struve
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Tahmine Fadai
- Department of Systems NeuroscienceUniversity Medical Centre Hamburg‐Eppendorf Hamburg Germany
| | - Viola Kappel
- Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus Charité MitteCharité‐Universitätsmedizin Berlin Berlin Germany
| | - Robert Goodman
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Arun L.W. Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of NeurosciencesTrinity College Dublin Ireland
| | - Uli Bromberg
- Department of Systems NeuroscienceUniversity Medical Centre Hamburg‐Eppendorf Hamburg Germany
| | - Rüdiger Brühl
- Physikalisch‐Technische Bundesanstalt, Abbestr. 2 ‐ 12 Berlin Germany
| | - Christian Büchel
- Department of Systems NeuroscienceUniversity Medical Centre Hamburg‐Eppendorf Hamburg Germany
| | - Anna Cattrell
- Medical Research Council—Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Patricia Conrod
- Department of PsychiatryMontreal University, CHU Ste Justine Hospital 3175 Côte-Ste-Catherine Montréal, Québec, H3T 1C5 Canada
| | - Sylvane Desrivières
- Medical Research Council—Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Juliane H. Fröhner
- Department of Psychiatry and PsychotherapyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany
| | - Vincent Frouin
- Neurospin, Commissariat à l'Energie Atomique, CEA‐Saclay Center Paris France
| | - Juergen Gallinat
- Department of Psychiatry and PsychotherapyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany
| | - Hugh Garavan
- Department of PsychiatryUniversity of Vermont Burlington Vermont
- Department of PsychologyUniversity of Vermont Burlington Vermont
| | - Penny Gowland
- Sir Peter Mansfield Imaging Centre School of Physics and AstronomyUniversity of Nottingham, University Park Nottingham UK
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité MitteCharité‐Universitätsmedizin Berlin Berlin Germany
| | - Sarah Hohmann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Sarah Jurk
- Department of Psychiatry and Neuroimaging CenterTechnische Universität Dresden Dresden Germany
| | - Sabina Millenet
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
| | | | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty MannheimHeidelberg University Mannheim Germany
- Department of Child and Adolescent Psychiatry and PsychotherapyMedical University of Vienna Vienna Austria
| | - Erin Burke Quinlan
- Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Michael N. Smolka
- Department of Psychiatry and Neuroimaging CenterTechnische Universität Dresden Dresden Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Campus Charité MitteCharité‐Universitätsmedizin Berlin Berlin Germany
| | - Robert Whelan
- Department of PsychologyUniversity College Dublin Ireland
| | - Gunter Schumann
- Medical Research Council—Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & NeuroscienceKing's College London London UK
| | - Jean‐Luc Martinot
- INSERM, UMR 1000, Research Unit “Neuroimaging and Psychiatry”, Paris Saclay University, Paris Descartes University, DIGITEO Labs, Gif sur Yvette France
- Center for Neuroimaging Research (CENIR)Brain & Spine Institute Paris France
| | | |
Collapse
|
6
|
Karow A, Brettschneider C, Helmut König H, Correll CU, Schöttle D, Lüdecke D, Rohenkohl A, Ruppelt F, Kraft V, Gallinat J, Lambert M. Better care for less money: cost-effectiveness of integrated care in multi-episode patients with severe psychosis. Acta Psychiatr Scand 2020; 141:221-230. [PMID: 31814102 DOI: 10.1111/acps.13139] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 12/04/2019] [Indexed: 12/24/2022]
Abstract
OBJECTIVE To compare cost-effectiveness of integrated care with therapeutic assertive community treatment (IC-TACT) versus standard care (SC) in multiple-episode psychosis. METHOD Twelve-month IC-TACT in patients with schizophrenia-spectrum and bipolar I disorders were compared with a historical control group. Primary outcomes were entropy-balanced cost-effectiveness based on mental healthcare costs from a payers' perspective and quality-adjusted life years (QALYs) as a measure of health effects during 12-month follow-up. RESULTS At baseline, patients in IC-TACT (n = 214) had significantly higher illness severity and lower functioning than SC (n = 56). Over 12 months, IC-TACT had significantly lower days in inpatient (10.3 ± 20.5 vs. 28.2 ± 44.9; P = 0.005) and day-clinic care (2.6 ± 16.7 vs. 16.4 ± 33.7; P = 0.004) and correspondingly lower costs (€-55 084). Within outpatient care, IC-TACT displayed a higher number of treatment contacts (116.3 ± 45.3 vs. 15.6 ± 6.3) and higher related costs (€+1417). Both resulted in lower total costs in IC-TACT (mean difference = €-13 248 ± 2975, P < 0.001). Adjusted incremental QALYs were significantly higher for IC-TACT versus SC (+0.10 ± 0.37, P = 0.05). The probability of cost-effectiveness of IC-TACT was constantly higher than 99%. CONCLUSION IC-TACT was cost-effective compared with SC. The use of prima facies 'costly' TACT teams is highly recommended to improve outcomes and save total cost for patients with severe psychotic disorders.
Collapse
Affiliation(s)
- A Karow
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - C Brettschneider
- Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - H Helmut König
- Department of Health Economics and Health Services Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - C U Correll
- Recognition and Prevention Program, Zucker Hillside Hospital, New York, NY, USA.,Department of Psychiatry and Molecular Medicine, Hofstra Northwell School of Medicine, New York, NY, USA.,Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany
| | - D Schöttle
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - D Lüdecke
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - A Rohenkohl
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - F Ruppelt
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - V Kraft
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - J Gallinat
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - M Lambert
- Competence Centre for Integrated Care in Mental Disorders, Centre for Psychosocial Medicine, Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| |
Collapse
|
7
|
Baker TE, Castellanos-Ryan N, Schumann G, Cattrell A, Flor H, Nees F, Banaschewski T, Bokde A, Whelan R, Buechel C, Bromberg U, Papadopoulos Orfanos D, Gallinat J, Garavan H, Heinz A, Walter H, Brühl R, Gowland P, Paus T, Poustka L, Martinot JL, Lemaitre H, Artiges E, Paillère Martinot ML, Smolka MN, Conrod P. Modulation of orbitofrontal-striatal reward activity by dopaminergic functional polymorphisms contributes to a predisposition to alcohol misuse in early adolescence. Psychol Med 2019; 49:801-810. [PMID: 29909784 DOI: 10.1017/s0033291718001459] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND Abnormalities in reward circuit function are considered a core feature of addiction. Yet, it is still largely unknown whether these abnormalities stem from chronic drug use, a genetic predisposition, or both. METHODS In the present study, we investigated this issue using a large sample of adolescent children by applying structural equation modeling to examine the effects of several dopaminergic polymorphisms of the D1 and D2 receptor type on the reward function of the ventral striatum (VS) and orbital frontal cortex (OFC), and whether this relationship predicted the propensity to engage in early alcohol misuse behaviors at 14 years of age and again at 16 years of age. RESULTS The results demonstrated a regional specificity with which the functional polymorphism rs686 of the D1 dopamine receptor (DRD1) gene and Taq1A of the ANKK1 gene influenced medial and lateral OFC activation during reward anticipation, respectively. Importantly, our path model revealed a significant indirect relationship between the rs686 of the DRD1 gene and early onset of alcohol misuse through a medial OFC × VS interaction. CONCLUSIONS These findings highlight the role of D1 and D2 in adjusting reward-related activations within the mesocorticolimbic circuitry, as well as in the susceptibility to early onset of alcohol misuse.
Collapse
Affiliation(s)
- Travis E Baker
- Department of Psychiatry,Universite de Montreal, CHU Ste Justine Hospital,Montreal,Canada
| | | | | | - Anna Cattrell
- Institute of Psychiatry, King's College London,London,UK
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim,Heidelberg University,Square J5, Mannheim,Germany
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim,Heidelberg University,Square J5, Mannheim,Germany
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry,Central Institute of Mental Health,Faculty of Clinical Medicine Mannheim,Medical Faculty Mannheim,Heidelberg University,Square J5, 68159 Mannheim,Germany
| | - Arun Bokde
- Discipline of Psychiatry,School of Medicine and Trinity College Institute of Neurosciences, Trinity College,Dublin,Ireland
| | - Rob Whelan
- Discipline of Psychiatry,School of Medicine and Trinity College Institute of Neurosciences, Trinity College,Dublin,Ireland
| | - Christian Buechel
- University Medical Centre Hamburg-Eppendorf,Haus S10, Martinistr. 52, Hamburg,Germany
| | - Uli Bromberg
- University Medical Centre Hamburg-Eppendorf,Haus S10, Martinistr. 52, Hamburg,Germany
| | | | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy,Campus Charité Mitte, Charité,Universitätsmedizin Berlin,Charitéplatz 1, Berlin,Germany
| | - Hugh Garavan
- Departments of Psychiatry and Psychology,University of Vermont,05405 Burlington, Vermont,USA
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy,Campus Charité Mitte, Charité,Universitätsmedizin Berlin,Charitéplatz 1, Berlin,Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy,Campus Charité Mitte, Charité,Universitätsmedizin Berlin,Charitéplatz 1, Berlin,Germany
| | - Rüdiger Brühl
- Physikalisch-Technische Bundesanstalt,Abbestr. 2 - 12, Berlin,Germany
| | - Penny Gowland
- School of Psychology, University of Nottingham, University Park,Nottingham,UK
| | - Tomáš Paus
- Rotman Research Institute, University of Toronto,Toronto,Canada
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry,Central Institute of Mental Health,Faculty of Clinical Medicine Mannheim,Medical Faculty Mannheim,Heidelberg University,Square J5, 68159 Mannheim,Germany
| | | | - Herve Lemaitre
- Institut National de la Sante et de la Recherche Medicale, INSERM CEAUnit1000, Imaging & Psychiatry, University Paris Sud,91400 Orsay,France
| | - Eric Artiges
- Department of Psychiatry,Universite de Montreal, CHU Ste Justine Hospital,Montreal,Canada
| | | | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center,Technische Universität Dresden,Dresden,Germany
| | - Patricia Conrod
- Department of Psychiatry,Universite de Montreal, CHU Ste Justine Hospital,Montreal,Canada
| |
Collapse
|
8
|
Ernst M, Benson B, Artiges E, Gorka AX, Lemaitre H, Lago T, Miranda R, Banaschewski T, Bokde ALW, Bromberg U, Brühl R, Büchel C, Cattrell A, Conrod P, Desrivières S, Fadai T, Flor H, Grigis A, Gallinat J, Garavan H, Gowland P, Grimmer Y, Heinz A, Kappel V, Nees F, Papadopoulos-Orfanos D, Penttilä J, Poustka L, Smolka MN, Stringaris A, Struve M, van Noort BM, Walter H, Whelan R, Schumann G, Grillon C, Martinot MLP, Martinot JL. Pubertal maturation and sex effects on the default-mode network connectivity implicated in mood dysregulation. Transl Psychiatry 2019; 9:103. [PMID: 30804326 PMCID: PMC6389927 DOI: 10.1038/s41398-019-0433-6] [Citation(s) in RCA: 35] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Revised: 10/11/2018] [Accepted: 01/01/2019] [Indexed: 01/03/2023] Open
Abstract
This study examines the effects of puberty and sex on the intrinsic functional connectivity (iFC) of brain networks, with a focus on the default-mode network (DMN). Consistently implicated in depressive disorders, the DMN's function may interact with puberty and sex in the development of these disorders, whose onsets peak in adolescence, and which show strong sex disproportionality (females > males). The main question concerns how the DMN evolves with puberty as a function of sex. These effects are expected to involve within- and between-network iFC, particularly, the salience and the central-executive networks, consistent with the Triple-Network Model. Resting-state scans of an adolescent community sample (n = 304, male/female: 157/147; mean/std age: 14.6/0.41 years), from the IMAGEN database, were analyzed using the AFNI software suite and a data reduction strategy for the effects of puberty and sex. Three midline regions (medial prefrontal, pregenual anterior cingulate, and posterior cingulate), within the DMN and consistently implicated in mood disorders, were selected as seeds. Within- and between-network clusters of the DMN iFC changed with pubertal maturation differently in boys and girls (puberty-X-sex). Specifically, pubertal maturation predicted weaker iFC in girls and stronger iFC in boys. Finally, iFC was stronger in boys than girls independently of puberty. Brain-behavior associations indicated that lower connectivity of the anterior cingulate seed predicted higher internalizing symptoms at 2-year follow-up. In conclusion, weaker iFC of the anterior DMN may signal disconnections among circuits supporting mood regulation, conferring risk for internalizing disorders.
Collapse
Affiliation(s)
| | | | - Eric Artiges
- INSERM, UMR 1000, Research unit "Neuroimaging and Psychiatry", DIGITEO Labs, University Paris-Saclay, and University Paris Descartes, Gif sur Yvette, France
- INSERM, UMR 1000, Faculté de médecine, University Paris-Saclay, DIGITEO Labs, Gif sur Yvette, France
- University Paris Descartes, Paris, France
- Center for Neuroimaging Research (CENIR), Brain & Spine Institute, Paris, France
- Psychiatry Department 91G16, Orsay Hospital, Paris, France
| | | | - Herve Lemaitre
- INSERM, UMR 1000, Research unit "Neuroimaging and Psychiatry", DIGITEO Labs, University Paris-Saclay, and University Paris Descartes, Gif sur Yvette, France
- INSERM, UMR 1000, Faculté de médecine, University Paris-Saclay, DIGITEO Labs, Gif sur Yvette, France
| | | | - Ruben Miranda
- INSERM, UMR 1000, Research unit "Neuroimaging and Psychiatry", DIGITEO Labs, University Paris-Saclay, and University Paris Descartes, Gif sur Yvette, France
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Arun L W Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin, Ireland
| | - Uli Bromberg
- University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Hamburg, Germany
| | - Rüdiger Brühl
- Physikalisch-Technische Bundesanstalt, Abbestr. 2 - 12, Berlin, Germany
| | - Christian Büchel
- University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Hamburg, Germany
| | - Anna Cattrell
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Patricia Conrod
- Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
- Department of Psychiatry, Université de Montréal, CHU Ste Justine Hospital, Montréal, QC, Canada
| | - Sylvane Desrivières
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Tahmine Fadai
- University Medical Centre Hamburg-Eppendorf, House W34, 3.OG, Hamburg, Germany
| | - Herta Flor
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany
| | - Antoine Grigis
- Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Saclay, France
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany
| | - Hugh Garavan
- Departments of Psychiatry and Psychology, University of Vermont, 05405, Burlington, VT, USA
| | - Penny Gowland
- Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom
| | - Yvonne Grimmer
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus CharitéMitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Viola Kappel
- Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus CharitéMitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Frauke Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Psychology, School of Social Sciences, University of Mannheim, 68131, Mannheim, Germany
| | | | - Jani Penttilä
- Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, University of Tampere, Kauppakatu 14, Lahti, Finland
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
- Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - Argyris Stringaris
- NIMH/NIH, Bethesda, MD, USA
- Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | - Maren Struve
- Department of Psychology, University College, Dublin, Ireland
| | - Betteke M van Noort
- Department of Child and Adolescent Psychiatry Psychosomatics and Psychotherapy, Campus CharitéMitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Campus CharitéMitte, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Robert Whelan
- Department of Psychology, University College, Dublin, Ireland
| | - Gunter Schumann
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom
| | | | - Marie-Laure Paillère Martinot
- INSERM, UMR 1000, Research unit "Neuroimaging and Psychiatry", DIGITEO Labs, University Paris-Saclay, and University Paris Descartes, Gif sur Yvette, France
- University Paris Descartes, Paris, France
- AP-HP, Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France
- Sorbonne Universités, Paris, France
| | - Jean-Luc Martinot
- INSERM, UMR 1000, Research unit "Neuroimaging and Psychiatry", DIGITEO Labs, University Paris-Saclay, and University Paris Descartes, Gif sur Yvette, France
- INSERM, UMR 1000, Faculté de médecine, University Paris-Saclay, DIGITEO Labs, Gif sur Yvette, France
- University Paris Descartes, Paris, France
- Center for Neuroimaging Research (CENIR), Brain & Spine Institute, Paris, France
| |
Collapse
|
9
|
Sebold M, Spitta G, Gleich T, Dembler-Stamm T, Butler O, Zacharias K, Aydin S, Garbusow M, Rapp M, Schubert F, Buchert R, Gallinat J, Heinz A. Stressful life events are associated with striatal dopamine receptor availability in alcohol dependence. J Neural Transm (Vienna) 2019; 126:1127-1134. [DOI: 10.1007/s00702-019-01985-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 02/06/2019] [Indexed: 11/30/2022]
|
10
|
Vulser H, Paillère Martinot ML, Artiges E, Miranda R, Penttilä J, Grimmer Y, van Noort BM, Stringaris A, Struve M, Fadai T, Kappel V, Goodman R, Tzavara E, Massaad C, Banaschewski T, Barker GJ, Bokde ALW, Bromberg U, Brühl R, Büchel C, Cattrell A, Conrod P, Desrivières S, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Nees F, Papadopoulos-Orfanos D, Paus T, Poustka L, Rodehacke S, Smolka MN, Walter H, Whelan R, Schumann G, Martinot JL, Lemaitre H. Early Variations in White Matter Microstructure and Depression Outcome in Adolescents With Subthreshold Depression. Am J Psychiatry 2018; 175:1255-1264. [PMID: 30111185 DOI: 10.1176/appi.ajp.2018.17070825] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE White matter microstructure alterations have recently been associated with depressive episodes during adolescence, but it is unknown whether they predate depression. The authors investigated whether subthreshold depression in adolescence is associated with white matter microstructure variations and whether they relate to depression outcome. METHOD Adolescents with subthreshold depression (N=96) and healthy control subjects (N=336) drawn from a community-based cohort were compared using diffusion tensor imaging and whole brain tract-based spatial statistics (TBSS) at age 14 to assess white matter microstructure. They were followed up at age 16 to assess depression. Probabilistic tractography was used to reconstruct white matter streamlines spreading from the regions identified in the TBSS analysis and along bundles implicated in emotion regulation, the uncinate fasciculus and the cingulum. The authors searched for mediating effects of white matter microstructure on the relationship between baseline subthreshold depression and depression at follow-up, and then explored the specificity of the findings. RESULTS Lower fractional anisotropy (FA) and higher radial diffusivity were found in the anterior corpus callosum in the adolescents with subthreshold depression. Tractography analysis showed that they also had lower FA in the right cingulum streamlines, along with lower FA and higher mean diffusivity in tracts connecting the corpus callosum to the anterior cingulate cortex. The relation between subthreshold depression at baseline and depression at follow-up was mediated by FA values in the latter tracts, and lower FA values in those tracts distinctively predicted higher individual risk for depression. CONCLUSIONS Early FA variations in tracts projecting from the corpus callosum to the anterior cingulate cortex may denote a higher risk of transition to depression in adolescents.
Collapse
Affiliation(s)
- Hélène Vulser
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Marie-Laure Paillère Martinot
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Eric Artiges
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Ruben Miranda
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Jani Penttilä
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Yvonne Grimmer
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Betteke M van Noort
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Argyris Stringaris
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Maren Struve
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Tahmine Fadai
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Viola Kappel
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Robert Goodman
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Eleni Tzavara
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Charbel Massaad
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Tobias Banaschewski
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Gareth J Barker
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Arun L W Bokde
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Uli Bromberg
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Rüdiger Brühl
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Christian Büchel
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Anna Cattrell
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Patricia Conrod
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Sylvane Desrivières
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Herta Flor
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Vincent Frouin
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Juergen Gallinat
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Hugh Garavan
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Penny Gowland
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Andreas Heinz
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Frauke Nees
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Dimitri Papadopoulos-Orfanos
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Tomas Paus
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Luise Poustka
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Sarah Rodehacke
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Michael N Smolka
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Henrik Walter
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Robert Whelan
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Gunter Schumann
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Jean-Luc Martinot
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | - Hervé Lemaitre
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| | -
- From INSERM, Research Unit UMR 1000, Research Unit "Neuroimaging and Psychiatry," Paris; University Paris-Saclay, Gif-sur-Yvette, France; University Paris Descartes, Paris; Assistance Publique-Hôpitaux de Paris, Department of Psychiatry, Western Paris University Hospital group, Paris; Assistance Publique-Hôpitaux de Paris, Child and Adolescent Psychiatry Department, Pitié-Salpêtrière Hospital, Paris the Center for Neuroimaging Research, Brain and Spine Institute, Paris; the Department of Psychiatry, Orsay Hospital, Orsay, France; the Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic, Lahti, Finland; the Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy and the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin; the Department of Child and Adolescent Psychiatry, the Centre for Neuroimaging Sciences, the Medical Research Council-Social, Genetic, and Developmental Psychiatry Centre, and the Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology, and Neuroscience, King's College London; the University Medical Center Hamburg-Eppendorf, Hamburg; Neuroscience Paris Seine-IBPS (CNRS UMR8246/Inserm U1130/UMPC UMCR18); Centre National de la Recherche Scientifique, Research Unit UMR 8194, Paris; the Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College, Dublin; Physikalisch-Technische Bundesanstalt, Berlin; the Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital, Montreal; Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris; the Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, U.K.; the Rotman Research Institute, University of Toronto, Toronto; the Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria; the Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany; the Department of Psychology, University College, Dublin
| |
Collapse
|
11
|
Castellanos-Ryan N, Brière FN, O'Leary-Barrett M, Banaschewski T, Bokde A, Bromberg U, Büchel C, Flor H, Frouin V, Gallinat J, Garavan H, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Robbins TW, Whelan R, Schumann G, Conrod P. The structure of psychopathology in adolescence and its common personality and cognitive correlates. J Abnorm Psychol 2018; 125:1039-1052. [PMID: 27819466 PMCID: PMC5098414 DOI: 10.1037/abn0000193] [Citation(s) in RCA: 134] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The traditional view that mental disorders are distinct, categorical disorders has been challenged by evidence that disorders are highly comorbid and exist on a continuum (e.g., Caspi et al., 2014; Tackett et al., 2013). The first objective of this study was to use structural equation modeling to model the structure of psychopathology in an adolescent community-based sample (N = 2,144) including conduct disorder, attention-deficit/hyperactivity disorder (ADHD), oppositional-defiant disorder (ODD), obsessive–compulsive disorder, eating disorders, substance use, anxiety, depression, phobias, and other emotional symptoms, assessed at 16 years. The second objective was to identify common personality and cognitive correlates of psychopathology, assessed at 14 years. Results showed that psychopathology at 16 years fit 2 bifactor models equally well: (a) a bifactor model, reflecting a general psychopathology factor, as well as specific externalizing (representing mainly substance misuse and low ADHD) and internalizing factors; and (b) a bifactor model with a general psychopathology factor and 3 specific externalizing (representing mainly ADHD and ODD), substance use and internalizing factors. The general psychopathology factor was related to high disinhibition/impulsivity, low agreeableness, high neuroticism and hopelessness, high delay-discounting, poor response inhibition and low performance IQ. Substance use was specifically related to high novelty-seeking, sensation-seeking, extraversion, high verbal IQ, and risk-taking. Internalizing psychopathology was specifically related to high neuroticism, hopelessness and anxiety-sensitivity, low novelty-seeking and extraversion, and an attentional bias toward negatively valenced verbal stimuli. Findings reveal several nonspecific or transdiagnostic personality and cognitive factors that may be targeted in new interventions to potentially prevent the development of multiple psychopathologies. This study provides support for a spectrum and common liability model of psychopathology, with findings showing that in a community sample of European adolescents: a) internalizing and externalizing psychopathology share substantial variance that can be modeled as a general psychopathology factor; and (b) that the common variance across psychopathologies is associated with personality traits related to high disinhibition/impulsivity, low agreeableness, high neuroticism and hopelessness, as well as different aspect of cognitive function, namely high delay-discounting, poor response inhibition and low performance IQ.
Collapse
Affiliation(s)
| | | | | | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University
| | - Arun Bokde
- Institute of Neuroscience, School of Medicine, Trinity College
| | - Uli Bromberg
- Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf
| | - Christian Büchel
- Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University
| | - Vincent Frouin
- Neurospin, Atomic Energy and Alternative Energies Commission
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf
| | | | - Jean-Luc Martinot
- Imaging and Psychiatry (Unit 1000), Institut National de la Santé et de la Recherche Médicale (INSERM CEA), University Paris Sud
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University
| | - Tomas Paus
- Rotman Research Institute, Department of Psychology, University of Toronto
| | | | - Marcella Rietschel
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University
| | | | | | | | - Gunter Schumann
- MRC Social, Genetic, and Developmental Psychiatry (SGDP) Centre
| | - Patricia Conrod
- Department of Psychiatry, University of Montreal, CHU Sainte-Justine Hospital
| |
Collapse
|
12
|
Abstract
BACKGROUND Most original studies and all meta-analyses conducted to date converge on the conclusion that patients with schizophrenia display rather generalized neurocognitive deficits. For the present study, we reopen this seemingly closed chapter and examine whether important influences, such as lack of motivation and negative attitudes towards cognitive assessment, result in poorer secondary neuropsychological performance. METHOD A sample of 50 patients with an established diagnosis of schizophrenia were tested for routine neurocognitive assessment and compared to 60 nonclinical volunteers. Before and after the assessment, subjective momentary influences were examined (e.g. motivation, concerns about assessment, fear about poor outcome) for their impact on performance using a new questionnaire called the Momentary Influences, Attitudes and Motivation Impact (MIAMI) on Cognitive Performance Scale. RESULTS As expected, patients performed significantly worse than controls on all neurocognitive domains tested (large effect size, on average). However, patients also displayed more subjective momentary impairment, as well as more fears about the outcome and less motivation than controls. Mediation analyses indicated that these influences contributed to (secondary) poorer neurocognitive performance. Differences in neurocognitive scores shrank to a medium effect size, on average, when MIAMI scores were accounted for. CONCLUSIONS The data argue that performance on measures of neurocognition in schizophrenia are to a considerable extent due to secondary factors. Poor motivation, fears and momentary impairments distinguished patients from controls and these variables heavily impacted performance. Before concluding that neurocognitive deficits in psychiatric patients are present, clinicians should take these confounding influences into account. Although patients with schizophrenia achieved, on average, worse test scores than controls, a large subgroup displayed spared performance.
Collapse
Affiliation(s)
- S Moritz
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg-Eppendorf,Martinistraße 52, 20246, Hamburg,Germany
| | - J P Klein
- Department of Psychiatry and Psychotherapy,Lübeck University,Ratzeburger Allee 160, 23538 Lübeck,Germany
| | - T Desler
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg-Eppendorf,Martinistraße 52, 20246, Hamburg,Germany
| | - H Lill
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg-Eppendorf,Martinistraße 52, 20246, Hamburg,Germany
| | - J Gallinat
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg-Eppendorf,Martinistraße 52, 20246, Hamburg,Germany
| | - B C Schneider
- Department of Psychiatry and Psychotherapy,University Medical Center Hamburg-Eppendorf,Martinistraße 52, 20246, Hamburg,Germany
| |
Collapse
|
13
|
Lambert M, Schöttle D, Ruppelt F, Rohenkohl A, Sengutta M, Luedecke D, Nawara LA, Galling B, Falk AL, Wittmann L, Niehaus V, Sarikaya G, Rietschel L, Gagern C, Schulte-Markwort M, Unger HP, Ott S, Romer G, Daubmann A, Wegscheider K, Correll CU, Schimmelmann BG, Wiedemann K, Bock T, Gallinat J, Karow A. Early detection and integrated care for adolescents and young adults with psychotic disorders: the ACCESS III study. Acta Psychiatr Scand 2017; 136:188-200. [PMID: 28589683 DOI: 10.1111/acps.12762] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 04/06/2017] [Indexed: 01/09/2023]
Abstract
OBJECTIVE The objective of the study was to investigate whether a combined intervention composed of early detection plus integrated care (EDIC) enhances outcomes in patients with early psychosis compared to standard care (SC). METHODS ACCESS III is a prospective non-randomized historical control design 1-year study examining the efficacy of EDIC (n = 120) vs. SC (n = 105) in patients aged 12-29 years. Primary outcome was the rate of ≥6 months combined symptomatic and functional remission. Additional outcomes comprised the reduction of DUP and course of psychopathology, functioning, quality of life, and satisfaction with care. RESULTS In observed cases, 48.9% in the EDIC and 15.2% in the SC group reached the primary endpoint. Remission was predicted by EDIC (OR = 6.8, CI: 3.15-14.53, P < 0.001); younger age predicted non-remission (OR = 1.1, CI: 1.01-1.19, P = 0.038). Linear regressions indicated a reduction of DUP in EDIC (P < 0.001), but not in SC (P = 0.41). MMRMs showed significantly larger improvements in PANSS positive (P < 0.001) and GAF (P < 0.01) scores in EDIC vs. SC, and in EDIC over time in CGI-Severity (P < 0.001) and numerically in Q-LES-Q-18 (P = 0.052). CONCLUSIONS EDIC lead to significantly higher proportions of patients achieving combined remission. Moderating variables included a reduction of DUP and EDIC, offering psychotherapeutic interventions.
Collapse
Affiliation(s)
- M Lambert
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - D Schöttle
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - F Ruppelt
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - A Rohenkohl
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - M Sengutta
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - D Luedecke
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.,Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, UKE, Hamburg, Germany
| | - L A Nawara
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - B Galling
- The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, USA
| | - A-L Falk
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - L Wittmann
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - V Niehaus
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - G Sarikaya
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - L Rietschel
- University Hospital of Child and Adolescent Psychiatry, University of Bern, Bern, Switzerland
| | - C Gagern
- Department of Clinical Psychology and Psychotherapy, University of Hamburg, Hamburg, Germany
| | - M Schulte-Markwort
- Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, UKE, Hamburg, Germany
| | - H-P Unger
- Center for Mental Health, Department of Psychiatry, Psychotherapy and Psychosomatics, Asklepios Hospital Harburg, Hamburg, Germany
| | - S Ott
- Center for Mental Health, Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, Asklepios Hospital Harburg, Hamburg, Germany
| | - G Romer
- Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Muenster, Münster, Germany
| | - A Daubmann
- Department of Medical Biometry and Epidemiology, UKE, Hamburg, Germany
| | - K Wegscheider
- Department of Medical Biometry and Epidemiology, UKE, Hamburg, Germany
| | - C U Correll
- The Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, USA
| | - B G Schimmelmann
- Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, UKE, Hamburg, Germany.,University Hospital of Child and Adolescent Psychiatry, University of Bern, Bern, Switzerland
| | - K Wiedemann
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - T Bock
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - J Gallinat
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany
| | - A Karow
- Psychosis Centre, Department of Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.,Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, UKE, Hamburg, Germany
| |
Collapse
|
14
|
Deng W, Rolls ET, Ji X, Robbins TW, Banaschewski T, Bokde ALW, Bromberg U, Buechel C, Desrivières S, Conrod P, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Lemaitre H, Nees F, Papadopoulos Orfanos D, Poustka L, Smolka MN, Walter H, Whelan R, Schumann G, Feng J. Separate neural systems for behavioral change and for emotional responses to failure during behavioral inhibition. Hum Brain Mapp 2017; 38:3527-3537. [PMID: 28429498 DOI: 10.1002/hbm.23607] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2017] [Accepted: 03/27/2017] [Indexed: 11/11/2022] Open
Abstract
To analyze the involvement of different brain regions in behavioral inhibition and impulsiveness, differences in activation were investigated in fMRI data from a response inhibition task, the stop-signal task, in 1709 participants. First, areas activated more in stop-success (SS) than stop-failure (SF) included the lateral orbitofrontal cortex (OFC) extending into the inferior frontal gyrus (ventrolateral prefrontal cortex, BA 47/12), and the dorsolateral prefrontal cortex (DLPFC). Second, the anterior cingulate and anterior insula (AI) were activated more on failure trials, specifically in SF versus SS. The interaction between brain region and SS versus SF activations was significant (P = 5.6 * 10-8 ). The results provide new evidence from this "big data" investigation consistent with the hypotheses that the lateral OFC is involved in the stop-related processing that inhibits the action; that the DLPFC is involved in attentional processes that influence task performance; and that the AI and anterior cingulate are involved in emotional processes when failure occurs. The investigation thus emphasizes the role of the human lateral OFC BA 47/12 in changing behavior, and inhibiting behavior when necessary. A very similar area in BA47/12 is involved in changing behavior when an expected reward is not obtained, and has been shown to have high functional connectivity in depression. Hum Brain Mapp 38:3527-3537, 2017. © 2017 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Wanlu Deng
- Shanghai Center for Mathematical Sciences, Fudan University, Shanghai, People's Republic of China.,Department of Computer Science, University of Warwick, Coventry, United Kingdom
| | - Edmund T Rolls
- Department of Computer Science, University of Warwick, Coventry, United Kingdom.,Oxford Centre for Computational Neuroscience, Oxford, United Kingdom
| | - Xiaoxi Ji
- Centre for Computational Systems Biology, School of Mathematical Sciences, School of Life Science and the Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, People's Republic of China
| | - Trevor W Robbins
- Department of Psychology, University of Cambridge, CB2 3EB, United Kingdom
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, 68159, Germany
| | - Arun L W Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Ireland
| | - Uli Bromberg
- University Medical Centre Hamburg-Eppendorf, Hamburg, 20246, Germany
| | - Christian Buechel
- University Medical Centre Hamburg-Eppendorf, Hamburg, 20246, Germany
| | - Sylvane Desrivières
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom
| | - Patricia Conrod
- Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montréal, Quebec, H3T 1C4, Canada.,Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Vincent Frouin
- Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris, France
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, 20246, Germany
| | - Hugh Garavan
- Departments of Psychiatry and Psychology, University of Vermont, 05405 Burlington, Vermont
| | - Penny Gowland
- Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, University Park, Nottingham, United Kingdom
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Bernd Ittermann
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany [or depending on journal requirements can be: Physikalisch-Technische Bundesanstalt (PTB)], Berlin, Germany
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud, University Paris Descartes - Sorbonne Paris Cité; and Maison de Solenn, Paris, France
| | - Herve Lemaitre
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 "Neuroimaging & Psychiatry", University Paris Sud, University Paris Descartes-Sorbonne Paris Cité, Paris, France.,Maison de Solenn, Paris, France
| | - Frauke Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, 68159, Germany
| | | | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, 68159, Germany.,Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Austria
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Charitéplatz 1, Berlin, Germany
| | - Robert Whelan
- Department of Psychology, University College Dublin, Ireland
| | - Gunter Schumann
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, United Kingdom
| | - Jianfeng Feng
- Shanghai Center for Mathematical Sciences, Fudan University, Shanghai, People's Republic of China.,Department of Computer Science, University of Warwick, Coventry, United Kingdom.,Centre for Computational Systems Biology, School of Mathematical Sciences, School of Life Science and the Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, People's Republic of China
| |
Collapse
|
15
|
Büchel C, Peters J, Banaschewski T, Bokde ALW, Bromberg U, Conrod PJ, Flor H, Papadopoulos D, Garavan H, Gowland P, Heinz A, Walter H, Ittermann B, Mann K, Martinot JL, Paillère-Martinot ML, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Robbins TW, Smolka MN, Gallinat J, Schumann G, Knutson B. Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents. Nat Commun 2017; 8:14140. [PMID: 28221370 PMCID: PMC5321762 DOI: 10.1038/ncomms14140] [Citation(s) in RCA: 74] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2015] [Accepted: 12/02/2016] [Indexed: 01/16/2023] Open
Abstract
Novelty-seeking tendencies in adolescents may promote innovation as well as problematic impulsive behaviour, including drug abuse. Previous research has not clarified whether neural hyper- or hypo-responsiveness to anticipated rewards promotes vulnerability in these individuals. Here we use a longitudinal design to track 144 novelty-seeking adolescents at age 14 and 16 to determine whether neural activity in response to anticipated rewards predicts problematic drug use. We find that diminished BOLD activity in mesolimbic (ventral striatal and midbrain) and prefrontal cortical (dorsolateral prefrontal cortex) regions during reward anticipation at age 14 predicts problematic drug use at age 16. Lower psychometric conscientiousness and steeper discounting of future rewards at age 14 also predicts problematic drug use at age 16, but the neural responses independently predict more variance than psychometric measures. Together, these findings suggest that diminished neural responses to anticipated rewards in novelty-seeking adolescents may increase vulnerability to future problematic drug use. Some adolescents seek novelty, but it is unknown whether the brain circuits underlying this behaviour can be used to predict later, problematic behaviour. Here, authors show that diminished ventral striatal and prefrontal activity in response to anticipated rewards at age 14 in these individuals predicts problematic drug use at age 16.
Collapse
Affiliation(s)
- Christian Büchel
- Department of Systems Neuroscience, Universitätsklinikum Hamburg Eppendorf, 20246 Hamburg, Germany.,Department of Psychology, Stanford University, Stanford, California 94305, USA
| | - Jan Peters
- Department of Systems Neuroscience, Universitätsklinikum Hamburg Eppendorf, 20246 Hamburg, Germany
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Arun L W Bokde
- Institute of Neuroscience and Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin 2, Ireland
| | - Uli Bromberg
- Department of Systems Neuroscience, Universitätsklinikum Hamburg Eppendorf, 20246 Hamburg, Germany
| | - Patricia J Conrod
- Institute of Psychiatry, King's College London, London SE5 8AF, UK.,Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montréal, Québec, Canada H3C 3J7
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Dimitri Papadopoulos
- Commissariat à l'Energie Atomique et aux Energies Alternatives, 14 CEA, DSV, I2BM, Neurospin bat 145, 91191 Gif-sur-Yvette, France
| | - Hugh Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland.,Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont 05401, USA
| | - Penny Gowland
- School of Physics and Astronomy, University of Nottingham, Nottinghamshire NG7 2RD, UK
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Bernd Ittermann
- Physikalisch-Technische Bundesanstalt (PTB), 10587 Berlin, Germany
| | - Karl Mann
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 'Imaging &Psychiatry', University Paris-Sud, 91400 Orsay, France.,Maison de Solenn, APHP Ho^pital Cochin, University Paris Descartes, 75006 Paris, France
| | - Marie-Laure Paillère-Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 'Imaging &Psychiatry', University Paris-Sud, 91400 Orsay, France.,Maison de Solenn, APHP Ho^pital Cochin, University Paris Descartes, 75006 Paris, France
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Tomas Paus
- McGill University and Genome Quebec Innovation Centre, Montréal, Québec, Canada H3A 1A4.,Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada M5S 3E6.,School of Psychology, University of Nottingham, Nottingham, Nottinghamshire NG7 2RD, UK.,Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada H3A 2B4
| | - Zdenka Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, Ontario Canada, M5G 1X8
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Marcella Rietschel
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany
| | - Trevor W Robbins
- Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, University of Cambridge, Cambridge CB2 3EB, UK
| | - Michael N Smolka
- Department of Psychiatry and Psychotherapy, and Neuroimaging Center, Technische Universität Dresden, 01307 Dresden, Germany
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Gunter Schumann
- Institute of Psychiatry, King's College London, London SE5 8AF, UK.,MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London SE5 8AF, UK
| | - Brian Knutson
- Department of Psychology, Stanford University, Stanford, California 94305, USA
| | | |
Collapse
|
16
|
Butler O, Adolf J, Gleich T, Willmund G, Zimmermann P, Lindenberger U, Gallinat J, Kühn S. Military deployment correlates with smaller prefrontal gray matter volume and psychological symptoms in a subclinical population. Transl Psychiatry 2017; 7:e1031. [PMID: 28195568 PMCID: PMC5438025 DOI: 10.1038/tp.2016.288] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/12/2016] [Revised: 10/26/2016] [Accepted: 11/13/2016] [Indexed: 02/04/2023] Open
Abstract
Research investigating the effects of trauma exposure on brain structure and function in adults has mainly focused on post-traumatic stress disorder (PTSD), whereas trauma-exposed individuals without a clinical diagnoses often serve as controls. However, this assumes a dichotomy between clinical and subclinical populations that may not be supported at the neural level. In the current study we investigate whether the effects of repeated or long-term stress exposure on brain structure in a subclinical sample are similar to previous PTSD neuroimaging findings. We assessed 27 combat trauma-exposed individuals by means of whole-brain voxel-based morphometry on 3 T magnetic resonance imaging scans and identified a negative association between duration of military deployment and gray matter volumes in ventromedial prefrontal cortex (vmPFC) and dorsal anterior cingulate cortex (ACC). We also found a negative relationship between deployment-related gray matter volumes and psychological symptoms, but not between military deployment and psychological symptoms. To our knowledge, this is the first whole-brain analysis showing that longer military deployment is associated with smaller regional brain volumes in combat-exposed individuals without PTSD. Notably, the observed gray matter associations resemble those previously identified in PTSD populations, and concern regions involved in emotional regulation and fear extinction. These findings question the current dichotomy between clinical and subclinical populations in PTSD neuroimaging research. Instead, neural correlates of both stress exposure and PTSD symptomatology may be more meaningfully investigated at a continuous level.
Collapse
Affiliation(s)
- O Butler
- Max Planck Institute for Human Development, Center for Lifespan Psychology, Berlin, Germany
| | - J Adolf
- Max Planck Institute for Human Development, Center for Lifespan Psychology, Berlin, Germany
| | - T Gleich
- Charité University Medicine, Campus Charité Mitte, Clinic for Psychiatry and Psychotherapy, Berlin, Germany
| | - G Willmund
- Psychotrauma Center of the German Military, Military Hospital Berlin, Berlin, Germany
| | - P Zimmermann
- Psychotrauma Center of the German Military, Military Hospital Berlin, Berlin, Germany
| | - U Lindenberger
- Max Planck Institute for Human Development, Center for Lifespan Psychology, Berlin, Germany
- European University Institute, Department of Political and Social Sciences, Badia Fiesolana, San Domenico di Fiesole, Italy
- Max Planck UCL Centre for Computational Psychiatry and Ageing Research, Berlin, Germany
| | - J Gallinat
- University Clinic Hamburg-Eppendorf, Clinic and Policlinic for Psychiatry and Psychotherapy, Hamburg, Germany
| | - S Kühn
- Max Planck Institute for Human Development, Center for Lifespan Psychology, Berlin, Germany
- University Clinic Hamburg-Eppendorf, Clinic and Policlinic for Psychiatry and Psychotherapy, Hamburg, Germany
| |
Collapse
|
17
|
Parchetka C, Strache N, Raffaelli B, Gemmeke I, Weiß K, Artiges E, Banaschewski T, Bokde A, Bromberg U, Buechel C, Conrod P, Desrivières S, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaitre H, Martinot JL, Mennigen E, Nees F, Paillère Martinot ML, Papadopoulos D, Paus T, Poustka L, Jurk S, Smolka MN, Vetter NC, Walter H, Whelan R, Schumann G, Gallinat J. Predictive utility of the NEO-FFI for later substance experiences among 16-year-old adolescents. J Public Health (Oxf) 2016. [DOI: 10.1007/s10389-016-0747-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
18
|
Burt KB, Whelan R, Conrod PJ, Banaschewski T, Barker GJ, Bokde ALW, Bromberg U, Büchel C, Fauth-Bühler M, Flor H, Galinowski A, Gallinat J, Gowland P, Heinz A, Ittermann B, Mann K, Nees F, Papadopoulos-Orfanos D, Paus T, Pausova Z, Poustka L, Rietschel M, Robbins TW, Smolka MN, Ströhle A, Schumann G, Garavan H. Structural brain correlates of adolescent resilience. J Child Psychol Psychiatry 2016; 57:1287-1296. [PMID: 27079174 DOI: 10.1111/jcpp.12552] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 01/26/2016] [Indexed: 11/30/2022]
Abstract
BACKGROUND Despite calls for integration of neurobiological methods into research on youth resilience (high competence despite high adversity), we know little about structural brain correlates of resilient functioning. The aim of the current study was to test for brain regions uniquely associated with positive functioning in the context of adversity, using detailed phenotypic classification. METHODS 1,870 European adolescents (Mage = 14.56 years, SDage = 0.44 years, 51.5% female) underwent MRI scanning and completed behavioral and psychological measures of stressful life events, academic competence, social competence, rule-abiding conduct, personality, and alcohol use. RESULTS The interaction of competence and adversity identified two regions centered on the right middle and superior frontal gyri; grey matter volumes in these regions were larger in adolescents experiencing adversity who showed positive adaptation. Differences in these regions among competence/adversity subgroups were maintained after controlling for several covariates and were robust to alternative operationalization decisions for key constructs. CONCLUSIONS We demonstrate structural brain correlates of adolescent resilience, and suggest that right prefrontal structures are implicated in adaptive functioning for youth who have experienced adversity.
Collapse
Affiliation(s)
- Keith B Burt
- Department of Psychology, University of Vermont, Burlington, VT, USA.
| | - Robert Whelan
- Department of Psychology, University College Dublin, Dublin, Ireland
| | - Patricia J Conrod
- Institute of Psychiatry, King's College London, London, UK.,Department of Psychiatry, CHU Ste Justine Hospital, Université de Montréal, Montreal, QC, Canada
| | - Tobias Banaschewski
- Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | | - Arun L W Bokde
- Institute of Neuroscience and Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - Uli Bromberg
- Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
| | | | - Mira Fauth-Bühler
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - André Galinowski
- Institut National de la Santé et de la Recherche Médicale, INSERM CEA Unit 1000 'Imaging & Psychiatry', University Paris Sud, Orsay, France.,AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Penny Gowland
- School of Physics and Astronomy, University of Nottingham, Nottingham, UK
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Bernd Ittermann
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig, Germany
| | - Karl Mann
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | | - Tomas Paus
- Rotman Research Institute, University of Toronto, Toronto, ON, Canada.,School of Psychology, University of Nottingham, Nottingham, UK.,Montreal Neurological Institute, McGill University, Montréal, QC, Canada
| | - Zdenka Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Marcella Rietschel
- Department of Cognitive and Clinical Neuroscience, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Trevor W Robbins
- Department of Experimental Psychology, Behavioural and Clinical Neurosciences Institute, University of Cambridge, Cambridge, UK
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - Andreas Ströhle
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - Gunter Schumann
- Institute of Psychiatry, King's College London, London, UK.,MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, UK
| | - Hugh Garavan
- Department of Psychology, University of Vermont, Burlington, VT, USA.,Department of Psychology, University College Dublin, Dublin, Ireland.,Department of Psychiatry, University of Vermont, Burlington, VT, USA
| | | |
Collapse
|
19
|
Gollier-Briant F, Paillère-Martinot ML, Lemaitre H, Miranda R, Vulser H, Goodman R, Penttilä J, Struve M, Fadai T, Kappel V, Poustka L, Grimmer Y, Bromberg U, Conrod P, Banaschewski T, Barker GJ, Bokde ALW, Büchel C, Flor H, Gallinat J, Garavan H, Heinz A, Lawrence C, Mann K, Nees F, Paus T, Pausova Z, Frouin V, Rietschel M, Robbins TW, Smolka MN, Schumann G, Martinot JL, Artiges E. Neural correlates of three types of negative life events during angry face processing in adolescents. Soc Cogn Affect Neurosci 2016; 11:1961-1969. [PMID: 27697987 DOI: 10.1093/scan/nsw100] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2014] [Revised: 07/01/2016] [Accepted: 07/21/2016] [Indexed: 12/20/2022] Open
Abstract
Negative life events (NLE) contribute to anxiety and depression disorders, but their relationship with brain functioning in adolescence has rarely been studied. We hypothesized that neural response to social threat would relate to NLE in the frontal-limbic emotional regions. Participants (N = 685) were drawn from the Imagen database of 14-year-old community adolescents recruited in schools. They underwent functional MRI while viewing angry and neutral faces, as a probe to neural response to social threat. Lifetime NLEs were assessed using the 'distress', 'family' and 'accident' subscales from a life event dimensional questionnaire. Relationships between NLE subscale scores and neural response were investigated. Links of NLE subscales scores with anxiety or depression outcomes at the age of 16 years were also investigated. Lifetime 'distress' positively correlated with ventral-lateral orbitofrontal and temporal cortex activations during angry face processing. 'Distress' scores correlated with the probabilities of meeting criteria for Generalized Anxiety Disorder or Major Depressive Disorder at the age of 16 years. Lifetime 'family' and 'accident' scores did not relate with neural response or follow-up conditions, however. Thus, different types of NLEs differentially predicted neural responses to threat during adolescence, and differentially predicted a de novo internalizing condition 2 years later. The deleterious effect of self-referential NLEs is suggested.
Collapse
Affiliation(s)
- Fanny Gollier-Briant
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France
| | - Marie-Laure Paillère-Martinot
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France.,AP-HP, Department of Adolescent Psychopathology and Medicine, Maison De Solenn, Cochin Hospital, Paris, France
| | - Hervé Lemaitre
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France
| | - Ruben Miranda
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France
| | - Hélène Vulser
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France
| | - Robert Goodman
- King's College London Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom
| | - Jani Penttilä
- University of Tampere, Medical School, Tampere, Finland
| | - Maren Struve
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Tahmine Fadai
- Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
| | - Viola Kappel
- Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Yvonne Grimmer
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Uli Bromberg
- Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
| | - Patricia Conrod
- CHU Ste Justine, Department of Psychiatry, Université De Montréal, Montréal, QC, Canada
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Gareth J Barker
- King's College London Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom
| | - Arun L W Bokde
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
| | - Christian Büchel
- Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, Campus CharitéMitte, Charité - Universitätsmedizin, Berlin, Germany
| | - Hugh Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.,Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus CharitéMitte, Charité - Universitätsmedizin, Berlin, Germany
| | - Claire Lawrence
- School of Psychology, University of Nottingham, Nottingham, United Kingdom
| | - Karl Mann
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.,Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | | - Zdenka Pausova
- Department of Physiology and Nutritional Sciences, the Hospital for Sick Children, University of Toronto, Toronto, Canada
| | - Vincent Frouin
- Neurospin, Commissariat à L'Energie Atomique Et Aux Energies Alternatives, Saclay, France
| | - Marcella Rietschel
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - Trevor W Robbins
- Psychology and Behavioural and Clinical neuroscience Institute, University of Cambridge, Cambridge, United Kingdom
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universit㲠Dresden, Germany
| | - Gunter Schumann
- King's College London Institute of Psychiatry, Psychology & Neuroscience, London, United Kingdom.,MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom
| | | | - Jean-Luc Martinot
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France .,CENIR Centre de Neuroimagerie de Recherche at Institute of Brain and Spine, Pitié - Salpétrière, Paris, France
| | - Eric Artiges
- INSERM, UMR 1000, Research Unit NeuroImaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, University Paris-Sud, University Paris Saclay, Orsay, and Maison De Solenn, University Paris Descartes, Paris, France.,Psychiatry Department, Orsay Hospital, Orsay, France
| |
Collapse
|
20
|
Raffaelli B, Strache N, Parchetka C, Artiges E, Banaschewski T, Bokde A, Bromberg U, Buechel C, Cattrell A, Conrod P, Flor H, Frouin V, Garavan H, Heinrich A, Heinz A, Ittermann B, Jurk S, Lemaitre H, Martinot JL, Mennigen E, Martinot MLP, Papadopoulos D, Paus T, Poustka L, Smolka MN, Vetter NC, Walter H, Whelan R, Schumann G, Gallinat J. Sex-related differences in frequency and perception of stressful life events during adolescence. J Public Health (Oxf) 2016. [DOI: 10.1007/s10389-016-0731-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
21
|
Heinz A, Voss M, Lawrie SM, Mishara A, Bauer M, Gallinat J, Juckel G, Lang U, Rapp M, Falkai P, Strik W, Krystal J, Abi-Dargham A, Galderisi S. Shall we really say goodbye to first rank symptoms? Eur Psychiatry 2016; 37:8-13. [PMID: 27429167 DOI: 10.1016/j.eurpsy.2016.04.010] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2016] [Revised: 04/18/2016] [Accepted: 04/19/2016] [Indexed: 01/12/2023] Open
Abstract
BACKGROUND First rank symptoms (FRS) of schizophrenia have been used for decades for diagnostic purposes. In the new version of the DSM-5, the American Psychiatric Association (APA) has abolished any further reference to FRS of schizophrenia and treats them like any other "criterion A" symptom (e.g. any kind of hallucination or delusion) with regard to their diagnostic implication. The ICD-10 is currently under revision and may follow suit. In this review, we discuss central points of criticism that are directed against the continuous use of first rank symptoms (FRS) to diagnose schizophrenia. METHODS We describe the specific circumstances in which Schneider articulated his approach to schizophrenia diagnosis and discuss the relevance of his approach today. Further, we discuss anthropological and phenomenological aspects of FRS and highlight the importance of self-disorder (as part of FRS) for the diagnosis of schizophrenia. Finally, we will conclude by suggesting that the theory and rationale behind the definition of FRS is still important for psychopathological as well as neurobiological approaches today. RESULTS Results of a pivotal meta-analysis and other studies show relatively poor sensitivity, yet relatively high specificity for FRS as diagnostic marker for schizophrenia. Several methodological issues impede a systematic assessment of the usefulness of FRS in the diagnosis of schizophrenia. However, there is good evidence that FRS may still be useful to differentiate schizophrenia from somatic causes of psychotic states. This may be particularly important in countries or situations with little access to other diagnostic tests. FRS may thus still represent a useful aid for clinicians in the diagnostic process. CONCLUSION In conclusion, we suggest to continue a tradition of careful clinical observation and fine-grained psychopathological assessment, including a focus on symptoms regarding self-disorders, which reflects a key aspect of psychosis. We suggest that the importance of FRS may indeed be scaled down to a degree that the occurrence of a single FRS alone should not suffice to diagnose schizophrenia, but, on the other hand, absence of FRS should be regarded as a warning sign that the diagnosis of schizophrenia or schizoaffective disorder is not warranted and requires specific care to rule out other causes, particularly neurological and other somatic disorders. With respect to the current stage of the development of ICD-11, we appreciate the fact that self-disorders are explicitly mentioned (and distinguished from delusions) in the list of mandatory symptoms but still feel that delusional perceptions and complex hallucinations as defined by Schneider should be distinguished from delusions or hallucinations of "any kind". Finally, we encourage future research to explore the psychopathological context and the neurobiological correlates of self-disorders as a potential phenotypic trait marker of schizophrenia.
Collapse
Affiliation(s)
- A Heinz
- Department of Psychiatry and Psychotherapy, Charité University Medicine, Saint-Hedwig Hospital, Humboldt University, Berlin, Germany
| | - M Voss
- Department of Psychiatry and Psychotherapy, Charité University Medicine, Saint-Hedwig Hospital, Humboldt University, Berlin, Germany.
| | - S M Lawrie
- Division of Psychiatry, University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK
| | - A Mishara
- Department of Clinical Psychology, Chicago School of Professional Psychology, Los Angeles, USA
| | - M Bauer
- University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
| | - J Gallinat
- University Clinic Hamburg-Eppendorf, Clinic and Policlinic for Psychiatry and Psychotherapy, Hamburg, Germany
| | - G Juckel
- Department of Psychiatry, Psychotherapy, and Psychosomatic Medicine, Ruhr-University, Bochum, Germany
| | - U Lang
- Psychiatric University Clinics (UPK), Basel, Switzerland
| | - M Rapp
- Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| | - P Falkai
- Department of Psychiatry and Psychotherapy, Ludwig-Maximilians University, Munich, Germany
| | - W Strik
- University Hospital of Psychiatry, University of Bern, Bern, Switzerland
| | - J Krystal
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
| | - A Abi-Dargham
- Department of Psychiatry, Columbia University, New York, NY, USA
| | - S Galderisi
- Department of Psychiatry, University of Naples SUN, Naples, Italy
| |
Collapse
|
22
|
Bohus M, Schmahl C, Herpertz SC, Lieb K, Berger M, Roepke S, Heinz A, Gallinat J, Lyssenko L. Leitliniengerechte stationäre psychiatrisch-psychotherapeutische Behandlung der Borderline-Persönlichkeitsstörung. Nervenarzt 2016; 87:739-45. [PMID: 27271516 DOI: 10.1007/s00115-016-0132-y] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- M Bohus
- Institut für Psychiatrische und Psychosomatische Psychotherapie, Zentralinstitut für Seelische Gesundheit, Universität Heidelberg, J 5, 68156, Mannheim, Deutschland.
- Fakultät für Gesundheit, Universität Antwerpen, Antwerpen, Belgien.
| | - C Schmahl
- Klinik für Psychosomatische Medizin und Psychotherapie, Zentralinstitut für Seelische Gesundheit, Universität Heidelberg, Mannheim, Deutschland
| | - S C Herpertz
- Klinik für Allgemeine Psychiatrie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Heidelberg, Universität Heidelberg, Heidelberg, Deutschland
| | - K Lieb
- Klinik für Psychiatrie und Psychotherapie der Universitätsmedizin Mainz, Mainz, Deutschland
| | - M Berger
- Klinik für Psychiatrie und Psychotherapie, Universität Freiburg, Freiburg, Deutschland
| | - S Roepke
- Klinik für Psychiatrie und Psychotherapie, Charité-Universitätsmedizin Berlin, Berlin, Deutschland
| | - A Heinz
- Klinik für Psychiatrie und Psychotherapie, Charité-Universitätsmedizin Berlin, Berlin, Deutschland
| | - J Gallinat
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland
| | - L Lyssenko
- Institut für Psychiatrische und Psychosomatische Psychotherapie, Zentralinstitut für Seelische Gesundheit, Universität Heidelberg, J 5, 68156, Mannheim, Deutschland
| |
Collapse
|
23
|
Mikita N, Simonoff E, Pine DS, Goodman R, Artiges E, Banaschewski T, Bokde AL, Bromberg U, Büchel C, Cattrell A, Conrod PJ, Desrivières S, Flor H, Frouin V, Gallinat J, Garavan H, Heinz A, Ittermann B, Jurk S, Martinot JL, Paillère Martinot ML, Nees F, Papadopoulos Orfanos D, Paus T, Poustka L, Smolka MN, Walter H, Whelan R, Schumann G, Stringaris A. Disentangling the autism-anxiety overlap: fMRI of reward processing in a community-based longitudinal study. Transl Psychiatry 2016; 6:e845. [PMID: 27351599 PMCID: PMC4931605 DOI: 10.1038/tp.2016.107] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/29/2016] [Revised: 04/01/2016] [Accepted: 04/20/2016] [Indexed: 12/28/2022] Open
Abstract
Up to 40% of youth with autism spectrum disorder (ASD) also suffer from anxiety, and this comorbidity is linked with significant functional impairment. However, the mechanisms of this overlap are poorly understood. We investigated the interplay between ASD traits and anxiety during reward processing, known to be affected in ASD, in a community sample of 1472 adolescents (mean age=14.4 years) who performed a modified monetary incentive delay task as part of the Imagen project. Blood-oxygen-level dependent (BOLD) responses to reward anticipation and feedback were compared using a 2x2 analysis of variance test (ASD traits: low/high; anxiety symptoms: low/high), controlling for plausible covariates. In addition, we used a longitudinal design to assess whether neural responses during reward processing predicted anxiety at 2-year follow-up. High ASD traits were associated with reduced BOLD responses in dorsal prefrontal regions during reward anticipation and negative feedback. Participants with high anxiety symptoms showed increased lateral prefrontal responses during anticipation, but decreased responses following feedback. Interaction effects revealed that youth with combined ASD traits and anxiety, relative to other youth, showed high right insula activation when anticipating reward, and low right-sided caudate, putamen, medial and lateral prefrontal activations during negative feedback (all clusters PFWE<0.05). BOLD activation patterns in the right dorsal cingulate and right medial frontal gyrus predicted new-onset anxiety in participants with high but not low ASD traits. Our results reveal both quantitatively enhanced and qualitatively distinct neural correlates underlying the comorbidity between ASD traits and anxiety. Specific neural responses during reward processing may represent a risk factor for developing anxiety in ASD youth.
Collapse
Affiliation(s)
- N Mikita
- Department of Child and Adolescent Psychiatry, King's CollegeLondon, Institute of Psychiatry, Psychology & Neuroscience, London, UK,Departmentof Child and Adolescent Psychiatry, PO85, King's College London, Institute of Psychiatry, Psychology & Neuroscience, De Crespigny Park, London SE5 8AF, UK. E-mail:
| | - E Simonoff
- Department of Child and Adolescent Psychiatry, King's CollegeLondon, Institute of Psychiatry, Psychology & Neuroscience, London, UK,NIHR Biomedical Research Centre and Dementia Unit at SouthLondon and Maudsley NHS Foundation Trust and the Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - D S Pine
- Section on Development and Affective Neuroscience, National Institute of Mental Health, Bethesda, MD, USA
| | - R Goodman
- Department of Child and Adolescent Psychiatry, King's CollegeLondon, Institute of Psychiatry, Psychology & Neuroscience, London, UK
| | - E Artiges
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 “Neuroimaging & Psychiatry”, Service Hospitalier Frédéric Joliot, Orsay, France,University Paris-Sud 11, Orsay, France,University Paris Descartes - Sorbonne Paris Cité, Paris, France,Psychiatry Department, Orsay Hospital, Orsay, France
| | - T Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - A L Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College, Dublin, Ireland
| | - U Bromberg
- University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - C Büchel
- University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - A Cattrell
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - P J Conrod
- Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada,Department of Psychological Medicine and Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - S Desrivières
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - H Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - V Frouin
- Neurospin, Commissariat à l'Energie Atomique, CEA-Saclay Center, Paris, France
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - H Garavan
- Department of Psychiatry, University of Vermont, Burlington, VT, USA,Department of Psychology, University of Vermont, Burlington, VT, USA
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Berlin, Germany
| | - B Ittermann
- Physikalisch-Technische Bundesanstalt, Braunschweig, Germany
| | - S Jurk
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - J L Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 “Neuroimaging & Psychiatry”, Service Hospitalier Frédéric Joliot, Orsay, France,University Paris-Sud 11, Orsay, France,University Paris Descartes - Sorbonne Paris Cité, Paris, France,AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris, France
| | - M L Paillère Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM Unit 1000 “Neuroimaging & Psychiatry”, Service Hospitalier Frédéric Joliot, Orsay, France,University Paris-Sud 11, Orsay, France,University Paris Descartes - Sorbonne Paris Cité, Paris, France,AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris, France
| | - F Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | | - T Paus
- Rotman Research Institute, Baycrest, Toronto, ON, Canada,Child Mind Institute, New York, NY, USA,Department of Psychology, University of Toronto, Toronto, ON, Canada,Department of Psychiatry, University of Toronto, Toronto, ON, Canada
| | - L Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany,Department of Child and Adolescent Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
| | - M N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - H Walter
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Berlin, Germany
| | - R Whelan
- Department of Psychology, University College Dublin, Dublin, Ireland
| | - G Schumann
- Medical Research Council - Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK
| | - A Stringaris
- Department of Child and Adolescent Psychiatry, King's CollegeLondon, Institute of Psychiatry, Psychology & Neuroscience, London, UK
| |
Collapse
|
24
|
Abstract
Until now, hypersexuality has not found entry into the common diagnostic classification systems. However it is a frequently discussed phenomenon consisting of excessive sexual appetite that is maladaptive for the individual. Initial studies investigated the neurobiological underpinnings of hypersexuality, but current literature is still insufficient to draw unequivocal conclusions. In the present review, we summarize and discuss findings from various perspectives: neuroimaging and lesion studies, studies on other neurological disorders that are sometimes accompanied by hypersexuality, neuropharmacological evidence, genetic as well as animal studies. Taken together, the evidence seems to imply that alterations in the frontal lobe, amygdala, hippocampus, hypothalamus, septum, and brain regions that process reward play a prominent role in the emergence of hypersexuality. Genetic studies and neuropharmacological treatment approaches point at an involvement of the dopaminergic system.
Collapse
Affiliation(s)
- S Kühn
- University Clinic Hamburg-Eppendorf, Clinic and Polyclinic for Psychiatry and Psychotherapy, Hamburg, Germany; Center for Lifespan Psychology, Max Planck Institute for Human Development, Berlin, Germany.
| | - J Gallinat
- University Clinic Hamburg-Eppendorf, Clinic and Polyclinic for Psychiatry and Psychotherapy, Hamburg, Germany
| |
Collapse
|
25
|
Mobascher A, Diaz-Lacava A, Wagner M, Gallinat J, Wienker TF, Drichel D, Becker T, Steffens M, Dahmen N, Gründer G, Thürauf N, Kiefer F, Kornhuber J, Toliat MR, Thiele H, Nürnberg P, Steinlein O, Winterer G. Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample. PLoS One 2016; 11:e0152984. [PMID: 27054571 PMCID: PMC4824511 DOI: 10.1371/journal.pone.0152984] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 03/22/2016] [Indexed: 12/16/2022] Open
Abstract
Variation in genes coding for nicotinic acetylcholine receptor (nAChR) subunits affect cognitive processes and may contribute to the genetic architecture of neuropsychiatric disorders. Single nucleotide polymorphisms (SNPs) in the CHRNA4 gene that codes for the alpha4 subunit of alpha4/beta2-containing receptors have previously been implicated in aspects of (mostly visual) attention and smoking-related behavioral measures. Here we investigated the effects of six synonymous but functional CHRNA4 exon 5 SNPs on the N100 event-related potential (ERP), an electrophysiological endophenotype elicited by a standard auditory oddball. A total of N = 1,705 subjects randomly selected from the general population were studied with electroencephalography (EEG) as part of the German Multicenter Study on nicotine addiction. Two of the six variants, rs1044396 and neighboring rs1044397, were significantly associated with N100 amplitude. This effect was pronounced in females where we also observed an effect on reaction time. Sequencing of the complete exon 5 region in the population sample excluded the existence of additional/functional variants that may be responsible for the observed effects. This is the first large-scale population-based study investigation the effects of CHRNA4 SNPs on brain activity measures related to stimulus processing and attention. Our results provide further evidence that common synonymous CHRNA4 exon 5 SNPs affect cognitive processes and suggest that they also play a role in the auditory system. As N100 amplitude reduction is considered a schizophrenia-related endophenotype the SNPs studied here may also be associated with schizophrenia outcome measures.
Collapse
Affiliation(s)
- A. Mobascher
- Department of Psychiatry, Mainz University Hospital, Mainz, Germany
| | - A. Diaz-Lacava
- Cologne Center for Genomics, University of Cologne, Cologne, Germany
| | - M. Wagner
- Department of Psychiatry, Bonn University Hospital, Bonn, Germany
| | - J. Gallinat
- Department of Psychiatry and Psychotherapy, University Medical Center Hamburg Eppendorf (UKE), Hamburg, Germany
| | - T. F. Wienker
- Max-Planck Institute for Molecular Genetics, Berlin, Germany
| | - D. Drichel
- University of Greifswald, Greifswald, Germany
| | - T. Becker
- University of Greifswald, Greifswald, Germany
| | - M. Steffens
- Research Division, Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany
| | - N. Dahmen
- Department of Psychiatry, Mainz University Hospital, Mainz, Germany
| | - G. Gründer
- Department of Psychiatry, Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, University Hospital, Aachen, Germany
| | - N. Thürauf
- Department of Psychiatry, Friedrich-Alexander University, University Hospital, Erlangen- Nürnberg, Erlangen, Germany
| | - F. Kiefer
- Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany
| | - J. Kornhuber
- Department of Psychiatry, Friedrich-Alexander University, University Hospital, Erlangen- Nürnberg, Erlangen, Germany
| | - M. R. Toliat
- Cologne Center for Genomics, University of Cologne, Cologne, Germany
| | - H. Thiele
- Cologne Center for Genomics, University of Cologne, Cologne, Germany
| | - P. Nürnberg
- Cologne Center for Genomics, University of Cologne, Cologne, Germany
| | - O. Steinlein
- Department of Human Genetics, Ludwig-Maximilians University, Munich, Germany
| | - G. Winterer
- Experimental and Clinical Research Center (ECRC), Charité – University Medicine, Berlin, Germany
| |
Collapse
|
26
|
Lambert M, Schöttle D, Ruppelt F, Lüdecke D, Sarikaya G, Schulte-Markwort M, Gallinat J, Karow A. [Integrated care for patients with first and multiple episodes of severe psychotic illnesses: 3-year results of the Hamburg model]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 58:408-19. [PMID: 25676450 DOI: 10.1007/s00103-015-2123-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
BACKGROUND The so-called "Hamburg model" is a designated integrated care model according to § 140 of the Social Code Book (SGB) V for psychosis patients fulfilling the definition of severe mental illness (SMI). OBJECTIVES Description of the model and evaluation of efficacy of all patients being treated for ≥ 3 years. MATERIALS AND METHODS Service entry illness status, course of illness, and interventions were assessed within a continuous quality assurance study. One hundred and fifty-eight patients who fulfilled the criterion of being treated for ≥ 3 years were analyzed. RESULTS At service entry, SMI were among others mirrored by a high level of psychopathology (Brief Psychiatric Rating Scale [BPRS]: 80.3) and severity of illness (Clinical Global Impression Severity [CGI-S]/Clinical Global Impression Bipolar scales [CGI-BP]: 5.8), low functioning level (Global Assessment of Functioning scale [GAF]: 35.9), and high rates of comorbid psychiatric (94.3 %) and somatic (81.6 %) disorders. Only 8 patients (5.1 %) disengaged from the service within the 3-year treatment period. The course of the illness over 3 years showed significant and stable improvements in psychopathology (BPRS: p < 0.001), the severity of illness (CGI-S/CGI-BP: p < 0.001), functioning (GAF: p < 0.001), quality of life (Quality of Life Enjoyment and Satisfaction Questionnaire [Q-LES-Q-18]: p < 0.001), and satisfaction with care (Client Satisfaction Questionnaire [CSQ-8]: 2.0 to 3.3; p = 0.164; nonsignificant because of early improvements). Further, compulsory admissions were reduced and medication adherence in addition to working ability improved (all p < 0.001). Data on interventions showed a continuously high frequency of outpatient interventions over time (on average 112.0 per year), a high percentage of patients in psychotherapy (67 %), and a nearly 90 % reduction in inpatient treatment days from year 1 to year 3. CONCLUSION Integrated care in severely ill patients with psychotic disorders leads to multidimensional illness improvement and stabilization by offering intensive outpatient care.
Collapse
Affiliation(s)
- Martin Lambert
- Arbeitsbereich Psychosen, Klinik für Psychiatrie und Psychotherapie, Zentrum für Psychosoziale Medizin, Universitätsklinikum Hamburg-Eppendorf (UKE), Martinistr. 52, 20246, Hamburg, Deutschland,
| | | | | | | | | | | | | | | |
Collapse
|
27
|
Cury C, Toro R, Cohen F, Fischer C, Mhaya A, Samper-González J, Hasboun D, Mangin JF, Banaschewski T, Bokde ALW, Bromberg U, Buechel C, Cattrell A, Conrod P, Flor H, Gallinat J, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaitre H, Martinot JL, Nees F, Paillère Martinot ML, Orfanos DP, Paus T, Poustka L, Smolka MN, Walter H, Whelan R, Frouin V, Schumann G, Glaunès JA, Colliot O. Incomplete Hippocampal Inversion: A Comprehensive MRI Study of Over 2000 Subjects. Front Neuroanat 2015; 9:160. [PMID: 26733822 PMCID: PMC4686650 DOI: 10.3389/fnana.2015.00160] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2015] [Accepted: 11/30/2015] [Indexed: 11/13/2022] Open
Abstract
The incomplete-hippocampal-inversion (IHI), also known as malrotation, is an atypical anatomical pattern of the hippocampus, which has been reported in healthy subjects in different studies. However, extensive characterization of IHI in a large sample has not yet been performed. Furthermore, it is unclear whether IHI are restricted to the medial-temporal lobe or are associated with more extensive anatomical changes. Here, we studied the characteristics of IHI in a community-based sample of 2008 subjects of the IMAGEN database and their association with extra-hippocampal anatomical variations. The presence of IHI was assessed on T1-weighted anatomical magnetic resonance imaging (MRI) using visual criteria. We assessed the association of IHI with other anatomical changes throughout the brain using automatic morphometry of cortical sulci. We found that IHI were much more frequent in the left hippocampus (left: 17%, right: 6%, χ(2)-test, p < 10(-28)). Compared to subjects without IHI, subjects with IHI displayed morphological changes in several sulci located mainly in the limbic lobe. Our results demonstrate that IHI are a common left-sided phenomenon in normal subjects and that they are associated with morphological changes outside the medial temporal lobe.
Collapse
Affiliation(s)
- Claire Cury
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France; Centre d'Acquisition et de Traitement des ImagesParis, France
| | - Roberto Toro
- Centre National de la Recherche Scientifique, Genes, Synapses and Cognition, URA 2182, Institut PasteurParis, France; Human Genetics and Cognitive Functions, Institut PasteurParis, France
| | - Fanny Cohen
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France
| | - Clara Fischer
- Centre d'Acquisition et de Traitement des ImagesParis, France; Institut d'Imagerie Biomédicale; Commissariat à l'énergie atomique et aux énergies alternatives; Direction des Sciences du VivantGif-Sur-Yvette, France
| | - Amel Mhaya
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France
| | - Jorge Samper-González
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France
| | - Dominique Hasboun
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France; Departments of Neuroradiology and Neurology, AP-HP, Hôpital de la Pitié-SalpétrièreParis, France
| | - Jean-François Mangin
- Centre d'Acquisition et de Traitement des ImagesParis, France; Institut d'Imagerie Biomédicale; Commissariat à l'énergie atomique et aux énergies alternatives; Direction des Sciences du VivantGif-Sur-Yvette, France
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Clinical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg Mannheim, Germany
| | - Arun L W Bokde
- Discipline of Psychiatry, School of Medicine, Trinity College DublinDublin, Ireland; Institute of Neuroscience, Trinity College DublinDublin, Ireland
| | - Uli Bromberg
- Department of Systems Neuroscience, Universitätsklinikum Hamburg Eppendorf Hamburg, Germany
| | - Christian Buechel
- Department of Systems Neuroscience, Universitätsklinikum Hamburg EppendorfHamburg, Germany; Department of Psychology, Stanford UniversityStanford, CA, USA
| | - Anna Cattrell
- Institute of Psychiatry, Psychology and Neuroscience, King's College LondonLondon, UK; MRC Social, Genetic and Developmental Psychiatry CentreLondon, UK
| | - Patricia Conrod
- Institute of Psychiatry, Psychology and Neuroscience, King's College LondonLondon, UK; Département de Psychiatrie, Centre Hospitalier Universitaire Sainte-Justine, Université de MontrealMontreal, QC, Canada
| | - Herta Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University Mannheim, Germany
| | - Juergen Gallinat
- Department of Systems Neuroscience, Universitätsklinikum Hamburg EppendorfHamburg, Germany; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin BerlinGermany
| | - Hugh Garavan
- Discipline of Psychiatry, School of Medicine, Trinity College Dublin Dublin, Ireland
| | - Penny Gowland
- School of Physics and Astronomy, University of Nottingham Nottingham, UK
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin Germany
| | | | - Hervé Lemaitre
- Institut national de la santé et de la recherche médicale U1000, Neuroimagerie en Psychiatrie, Université Paris-Sud, Université Paris Descartes Paris, France
| | - Jean-Luc Martinot
- Institut national de la santé et de la recherche médicale U1000, Neuroimagerie en Psychiatrie, Université Paris-Sud, Université Paris Descartes Paris, France
| | - Frauke Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University Mannheim, Germany
| | - Marie-Laure Paillère Martinot
- Institut national de la santé et de la recherche médicale U1000, Neuroimagerie en Psychiatrie, Université Paris-Sud, Université Paris DescartesParis, France; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, University Paris Descartes, Sorbonne Paris CitéParis, France
| | - Dimitri P Orfanos
- Institut d'Imagerie Biomédicale; Commissariat à l'énergie atomique et aux énergies alternatives; Direction des Sciences du Vivant Gif-Sur-Yvette, France
| | - Tomas Paus
- Rotman Research Institute, BaycrestToronto, ON, Canada; Departments of Psychology and Psychiatry, University of TorontoToronto, Canada; Center for Developing Brain, Child Mind InstituteNew York, NY, USA
| | - Luise Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Clinical Faculty Mannheim, Central Institute of Mental Health, University of HeidelbergMannheim, Germany; Department of Child and Adolescent Psychiatry, Medical University of ViennaVienna, Austria
| | - Michael N Smolka
- Department of Psychiatry and Neuroimaging Center, Technische Universität Dresden Dresden, Germany
| | - Henrik Walter
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin BerlinGermany; Berlin School of Mind and Brain, Humboldt University BerlinBerlin, Germany
| | - Robert Whelan
- Department of Psychology, University College Dublin Dublin, Ireland
| | - Vincent Frouin
- Institut d'Imagerie Biomédicale; Commissariat à l'énergie atomique et aux énergies alternatives; Direction des Sciences du Vivant Gif-Sur-Yvette, France
| | - Gunter Schumann
- Institute of Psychiatry, Psychology and Neuroscience, King's College LondonLondon, UK; MRC Social, Genetic and Developmental Psychiatry CentreLondon, UK
| | - Joan A Glaunès
- MAP5, Université Paris Descartes, Sorbonne Paris Cité Paris, France
| | - Olivier Colliot
- Institut national de la santé et de la recherche médicale, U1127Paris, France; Centre National de la Recherche Scientifique, UMR 7225 Institut du Cerveau et de la Moelle épinièreParis, France; Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, UMR S 1127Paris, France; Institut du Cerveau et de la Moelle épinière, Institut du Cerveau et de la Moelle épinièreParis, France; Inria, Aramis Team, Centre de Recherche Paris-RocquencourtParis, France; Centre d'Acquisition et de Traitement des ImagesParis, France; Departments of Neuroradiology and Neurology, AP-HP, Hôpital de la Pitié-SalpétrièreParis, France
| | | |
Collapse
|
28
|
Stringaris A, Vidal-Ribas Belil P, Artiges E, Lemaitre H, Gollier-Briant F, Wolke S, Vulser H, Miranda R, Penttilä J, Struve M, Fadai T, Kappel V, Grimmer Y, Goodman R, Poustka L, Conrod P, Cattrell A, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Ittermann B, Nees F, Papadopoulos D, Paus T, Smolka MN, Walter H, Whelan R, Martinot JL, Schumann G, Paillère-Martinot ML. The Brain's Response to Reward Anticipation and Depression in Adolescence: Dimensionality, Specificity, and Longitudinal Predictions in a Community-Based Sample. Am J Psychiatry 2015; 172:1215-23. [PMID: 26085042 PMCID: PMC7614275 DOI: 10.1176/appi.ajp.2015.14101298] [Citation(s) in RCA: 173] [Impact Index Per Article: 19.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE The authors examined whether alterations in the brain's reward network operate as a mechanism across the spectrum of risk for depression. They then tested whether these alterations are specific to anhedonia as compared with low mood and whether they are predictive of depressive outcomes. METHOD Functional MRI was used to collect blood-oxygen-level-dependent (BOLD) responses to anticipation of reward in the monetary incentive task in 1,576 adolescents in a community-based sample. Adolescents with current subthreshold depression and clinical depression were compared with matched healthy subjects. In addition, BOLD responses were compared across adolescents with anhedonia, low mood, or both symptoms, cross-sectionally and longitudinally. RESULTS Activity in the ventral striatum was reduced in participants with subthreshold and clinical depression relative to healthy comparison subjects. Low ventral striatum activation predicted transition to subthreshold or clinical depression in previously healthy adolescents at 2-year follow-up. Brain responses during reward anticipation decreased in a graded manner between healthy adolescents, adolescents with current or future subthreshold depression, and adolescents with current or future clinical depression. Low ventral striatum activity was associated with anhedonia but not low mood; however, the combined presence of both symptoms showed the strongest reductions in the ventral striatum in all analyses. CONCLUSIONS The findings suggest that reduced striatal activation operates as a mechanism across the risk spectrum for depression. It is associated with anhedonia in healthy adolescents and is a behavioral indicator of positive valence systems, consistent with predictions based on the Research Domain Criteria.
Collapse
Affiliation(s)
- Argyris Stringaris
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Pablo Vidal-Ribas Belil
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Eric Artiges
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Hervé Lemaitre
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Fanny Gollier-Briant
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Selina Wolke
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Hélène Vulser
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Ruben Miranda
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Jani Penttilä
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Maren Struve
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Tahmine Fadai
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Viola Kappel
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Yvonne Grimmer
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Robert Goodman
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Luise Poustka
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Patricia Conrod
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Anna Cattrell
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Tobias Banaschewski
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Arun L W Bokde
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Uli Bromberg
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Christian Büchel
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Herta Flor
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Vincent Frouin
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Juergen Gallinat
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Hugh Garavan
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Penny Gowland
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Andreas Heinz
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Bernd Ittermann
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Frauke Nees
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Dimitri Papadopoulos
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Tomas Paus
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Michael N Smolka
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Henrik Walter
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Rob Whelan
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Jean-Luc Martinot
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Gunter Schumann
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Marie-Laure Paillère-Martinot
- From the Department of Child and Adolescent Psychiatry, King's College London, Institute of Psychiatry, Psychology, and Neuroscience, London; INSERM, UMR 1000, Research Unit Imaging and Psychiatry, Service Hospitalier Frédéric Joliot, Orsay, France; University Paris-Sud 11, Orsay; Paris Descartes University, Sorbonne Paris Cité, Paris; AP-HP, Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris; Psychiatry Department 91G16, Orsay Hospital, Orsay; Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris; Department of Social and Health Care, Psychosocial Services Adolescent Outpatient Clinic Kauppakatu 14, Lahti, Finland; Department of Psychiatry, University of Montreal, CHU Ste Justine Hospital, Montreal; Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany; Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Charité-Universitätsmedizin, Berlin, Germany; Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Germany; Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; MRC Social, Genetic, and Developmental Psychiatry Centre, London; Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; Departments of Psychiatry and Psychology, University of Vermont, Burlington; School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom; Physikalisch-Technische Bundesanstalt, Braunschweig and Berlin; Rotman Research Institute, University of Toronto, Toronto; Department of Psychiatry and Psychotherapy and the Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | | |
Collapse
|
29
|
Toro R, Poline JB, Huguet G, Loth E, Frouin V, Banaschewski T, Barker GJ, Bokde A, Büchel C, Carvalho FM, Conrod P, Fauth-Bühler M, Flor H, Gallinat J, Garavan H, Gowland P, Heinz A, Ittermann B, Lawrence C, Lemaître H, Mann K, Nees F, Paus T, Pausova Z, Rietschel M, Robbins T, Smolka MN, Ströhle A, Schumann G, Bourgeron T. Genomic architecture of human neuroanatomical diversity. Mol Psychiatry 2015; 20:1011-6. [PMID: 25224261 DOI: 10.1038/mp.2014.99] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2014] [Revised: 06/02/2014] [Accepted: 07/14/2014] [Indexed: 02/06/2023]
Abstract
Human brain anatomy is strikingly diverse and highly inheritable: genetic factors may explain up to 80% of its variability. Prior studies have tried to detect genetic variants with a large effect on neuroanatomical diversity, but those currently identified account for <5% of the variance. Here, based on our analyses of neuroimaging and whole-genome genotyping data from 1765 subjects, we show that up to 54% of this heritability is captured by large numbers of single-nucleotide polymorphisms of small-effect spread throughout the genome, especially within genes and close regulatory regions. The genetic bases of neuroanatomical diversity appear to be relatively independent of those of body size (height), but shared with those of verbal intelligence scores. The study of this genomic architecture should help us better understand brain evolution and disease.
Collapse
Affiliation(s)
- R Toro
- 1] Human Genetics and Cognitive Functions, Neuroscience Department, Institut Pasteur, Paris, France [2] CNRS URA 2182 'Genes, synapses and cognition', Paris, France [3] Université Paris Diderot, Sorbonne Paris Cité, Human Genetics and Cognitive Functions, Paris, France
| | - J-B Poline
- 1] Henry H. Wheeler, Jr. Brain Imaging Center, University of California at Berkeley, Berkeley, CA, USA [2] Neurospin, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Paris, France
| | - G Huguet
- 1] Human Genetics and Cognitive Functions, Neuroscience Department, Institut Pasteur, Paris, France [2] CNRS URA 2182 'Genes, synapses and cognition', Paris, France [3] Université Paris Diderot, Sorbonne Paris Cité, Human Genetics and Cognitive Functions, Paris, France
| | - E Loth
- 1] Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King's College London, London, UK [2] MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK
| | - V Frouin
- Henry H. Wheeler, Jr. Brain Imaging Center, University of California at Berkeley, Berkeley, CA, USA
| | - T Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - G J Barker
- Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King's College London, London, UK
| | - A Bokde
- Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Dublin, Ireland
| | - C Büchel
- University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
| | - F M Carvalho
- 1] Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King's College London, London, UK [2] MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK
| | - P Conrod
- 1] Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King's College London, London, UK [2] Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada
| | - M Fauth-Bühler
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - H Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - H Garavan
- 1] Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neurosciences, Trinity College Dublin, Dublin, Ireland [2] Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - P Gowland
- Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - B Ittermann
- Physikalisch-Technische Bundesanstalt, Berlin, Germany
| | - C Lawrence
- School of Psychology, University of Nottingham, Nottingham, UK
| | - H Lemaître
- 1] Institut National de la Santé et de la Recherche Medicale, INSERM CEA Unit 1000, 'Imaging & Psychiatry', University Paris Sud, Orsay, France [2] Department of Adolescent Psychopathology and Medicine, Assistance Publique Hôpitaux de Paris, Maison de Solenn, Université Paris Descartes, Paris, France
| | - K Mann
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - F Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - T Paus
- 1] School of Psychology, University of Nottingham, Nottingham, UK [2] Psychology and Psychiatry Department, Rotman Research Institute, University of Toronto, Toronto, ON, Canada [3] Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada
| | - Z Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - M Rietschel
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - T Robbins
- Department of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK
| | - M N Smolka
- 1] Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany [2] Department of Psychology, Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - A Ströhle
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany
| | - G Schumann
- 1] Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, King's College London, London, UK [2] MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK [3] Fondamental Foundation, Créteil, France
| | - T Bourgeron
- 1] Human Genetics and Cognitive Functions, Neuroscience Department, Institut Pasteur, Paris, France [2] CNRS URA 2182 'Genes, synapses and cognition', Paris, France [3] Université Paris Diderot, Sorbonne Paris Cité, Human Genetics and Cognitive Functions, Paris, France [4] Fondamental Foundation, Créteil, France
| | | |
Collapse
|
30
|
Galinowski A, Miranda R, Lemaitre H, Paillère Martinot ML, Artiges E, Vulser H, Goodman R, Penttilä J, Struve M, Barbot A, Fadai T, Poustka L, Conrod P, Banaschewski T, Barker GJ, Bokde A, Bromberg U, Büchel C, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Kappel V, Lawrence C, Loth E, Mann K, Nees F, Paus T, Pausova Z, Poline JB, Rietschel M, Robbins TW, Smolka M, Schumann G, Martinot JL. Resilience and corpus callosum microstructure in adolescence. Psychol Med 2015; 45:2285-2294. [PMID: 25817177 DOI: 10.1017/s0033291715000239] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
BACKGROUND Resilience is the capacity of individuals to resist mental disorders despite exposure to stress. Little is known about its neural underpinnings. The putative variation of white-matter microstructure with resilience in adolescence, a critical period for brain maturation and onset of high-prevalence mental disorders, has not been assessed by diffusion tensor imaging (DTI). Lower fractional anisotropy (FA) though, has been reported in the corpus callosum (CC), the brain's largest white-matter structure, in psychiatric and stress-related conditions. We hypothesized that higher FA in the CC would characterize stress-resilient adolescents. METHOD Three groups of adolescents recruited from the community were compared: resilient with low risk of mental disorder despite high exposure to lifetime stress (n = 55), at-risk of mental disorder exposed to the same level of stress (n = 68), and controls (n = 123). Personality was assessed by the NEO-Five Factor Inventory (NEO-FFI). Voxelwise statistics of DTI values in CC were obtained using tract-based spatial statistics. Regional projections were identified by probabilistic tractography. RESULTS Higher FA values were detected in the anterior CC of resilient compared to both non-resilient and control adolescents. FA values varied according to resilience capacity. Seed regional changes in anterior CC projected onto anterior cingulate and frontal cortex. Neuroticism and three other NEO-FFI factor scores differentiated non-resilient participants from the other two groups. CONCLUSION High FA was detected in resilient adolescents in an anterior CC region projecting to frontal areas subserving cognitive resources. Psychiatric risk was associated with personality characteristics. Resilience in adolescence may be related to white-matter microstructure.
Collapse
Affiliation(s)
- A Galinowski
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - R Miranda
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - H Lemaitre
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - M-L Paillère Martinot
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - E Artiges
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - H Vulser
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| | - R Goodman
- King's College, London Institute of Psychiatry,London,UK
| | - J Penttilä
- Psychiatry Department,University of Tampere,School of Medicine, Tampere,Finland
| | - M Struve
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | | | - T Fadai
- Universitaetsklinikum Hamburg Eppendorf,Hamburg,Germany
| | - L Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - P Conrod
- King's College, London Institute of Psychiatry,London,UK
| | - T Banaschewski
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - G J Barker
- King's College, London Institute of Psychiatry,London,UK
| | - A Bokde
- Institute of Neuroscience and Department of Psychiatry,School of Medicine,Trinity College Dublin,Dublin,Ireland
| | - U Bromberg
- Universitaetsklinikum Hamburg Eppendorf,Hamburg,Germany
| | - C Büchel
- Universitaetsklinikum Hamburg Eppendorf,Hamburg,Germany
| | - H Flor
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - J Gallinat
- Department of Psychiatry and Psychotherapy,Campus Charité Mitte,Charité-Universitätsmedizin,Berlin,Germany
| | - H Garavan
- Institute of Neuroscience,Trinity College Dublin,Dublin,Ireland
| | - A Heinz
- Department of Psychiatry and Psychotherapy,Campus Charité Mitte,Charité-Universitätsmedizin,Berlin,Germany
| | - B Ittermann
- Physikalisch-Technische Bundesanstalt (PTB),Braunschweig und Berlin,Germany
| | - V Kappel
- Department of Child and Adolescent Psychiatry,Psychosomatics and Psychotherapy,Charité-Universitätsmedizin,Berlin,Germany
| | - C Lawrence
- School of Psychology,University of Nottingham,UK
| | - E Loth
- King's College, London Institute of Psychiatry,London,UK
| | - K Mann
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - F Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - T Paus
- School of Psychology,University of Nottingham,UK
| | - Z Pausova
- Department of Physiology and Nutritional Sciences,The Hospital for Sick Children,University of Toronto,Toronto, ONT,Canada
| | | | - M Rietschel
- Department of Cognitive and Clinical Neuroscience,Central Institute of Mental Health,Medical Faculty Mannheim/Heidelberg University,Germany
| | - T W Robbins
- Department of Experimental Psychology,Behavioural and Clinical Neurosciences Institute,University of Cambridge,UK
| | - M Smolka
- Department of Psychiatry and Psychotherapy,Technische Universität Dresden,Germany
| | - G Schumann
- King's College, London Institute of Psychiatry,London,UK
| | - J-L Martinot
- INSERM,UMR 1000,Research unit Imaging and Psychiatry,Service Hospitalier Frédéric Joliot,Orsay,France
| |
Collapse
|
31
|
Lang UE, Ackermann TF, Wolfer D, Schubert F, Sohr R, Hörtnagl H, Lang F, Gallinat J. Phosphoinositide-Dependent Protein Kinase 1 (PDK1). Zeitschrift für Psychologie 2015. [DOI: 10.1027/2151-2604/a000217] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Abstract. Phosphatidylinositol-3-kinase (PI3K) signaling influences susceptibility to virus infections, anoxia, obstetric complications, and cancer; which are changed in patients with schizophrenia and their first degree relatives. Therefore PI3K signaling might have impact on the pathophysiology of schizophrenia. PI3K signaling crucially involves phosphoinositide-dependent protein kinase (PDK1). Increased anxiety behavior is observed in PDK1 hypomorphic mice. Here we show enhanced prevalence of schizophrenia in carriers of the PDK1 CC genotype in human beings. Moreover, decreased parietal P300 amplitude, which is a well-studied schizophrenic endophenotype, was observed in PDK1 CC carriers. Glutamate and glutamine concentrations are increased in the frontal lobe of PDK1 dysmorphic mice and human CC individuals. Our results demonstrate that the PDK1 CC genotype is associated with increased risk to develop schizophrenia, a typical endophenotype profile observed in the disease and modified neurotransmitter concentrations in brain regions associated with the disease.
Collapse
Affiliation(s)
- Undine E. Lang
- Department of Psychiatry and Psychotherapy, University of Basel, Switzerland
| | | | - David Wolfer
- Institute of Anatomy, University of Zurich and Department of Biology, ETH Zurich, Switzerland
| | | | - Reinhard Sohr
- Department of Pharmacology, Charité University Medicine Berlin, Germany
| | - Heide Hörtnagl
- Department of Pharmacology, University of Innsbruck, Austria
| | - Florian Lang
- Department of Physiology I, University of Tuebingen, Germany
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, University Hospital Hamburg, Germany
| |
Collapse
|
32
|
Nees F, Witt SH, Dinu-Biringer R, Lourdusamy A, Tzschoppe J, Vollstädt-Klein S, Millenet S, Bach C, Poustka L, Banaschewski T, Barker GJ, Bokde ALW, Bromberg U, Büchel C, Conrod PJ, Frank J, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Ittermann B, Mann K, Martinot JL, Paus T, Pausova Z, Robbins TW, Smolka MN, Rietschel M, Schumann G, Flor H. BDNF Val66Met and reward-related brain function in adolescents: role for early alcohol consumption. Alcohol 2015; 49:103-10. [PMID: 25650137 DOI: 10.1016/j.alcohol.2014.12.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2014] [Revised: 12/22/2014] [Accepted: 12/22/2014] [Indexed: 11/28/2022]
Abstract
Changes in reward processing have been identified as one important pathogenetic mechanism in alcohol addiction. The nonsynonymous single nucleotide polymorphism in the brain-derived neurotrophic factor (BDNF) gene (rs6265/Val66Met) modulates the central nervous system activity of neurotransmitters involved in reward processing such as serotonin, dopamine, and glutamate. It was identified as crucial for alcohol consumption in healthy adults and, in rats, specifically related to the function in the striatum, a region that is commonly involved in reward processing. However, studies in humans on the association of BDNF Val66Met and reward-related brain functions and its role for alcohol consumption, a significant predictor of later alcohol addiction, are missing. Based on an intermediate phenotype approach, we assessed the early orientation toward alcohol and alcohol consumption in 530 healthy adolescents that underwent a monetary incentive delay task during functional magnetic resonance imaging. We found a significantly lower response in the putamen to reward anticipation in adolescent Met carriers with high versus low levels of alcohol consumption. During reward feedback, Met carriers with low putamen reactivity were significantly more likely to orient toward alcohol and to drink alcohol 2 years later. This study indicates a possible effect of BDNF Val66Met on alcohol addiction-related phenotypes in adolescence.
Collapse
Affiliation(s)
- F Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
| | - S H Witt
- Division of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - R Dinu-Biringer
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Department of Clinical Psychology and Psychotherapy, Ruprecht-Karls University Heidelberg, Heidelberg, Germany
| | - A Lourdusamy
- Institute of Psychiatry, King's College London, United Kingdom; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom
| | - J Tzschoppe
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - S Vollstädt-Klein
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - S Millenet
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - C Bach
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - L Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - T Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - G J Barker
- Institute of Psychiatry, King's College London, United Kingdom
| | - A L W Bokde
- Institute of Neuroscience and Discipline of Psychiatry, School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - U Bromberg
- NeuroImage Nord, Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany
| | - C Büchel
- NeuroImage Nord, Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Germany
| | - P J Conrod
- Institute of Psychiatry, King's College London, United Kingdom; Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Canada
| | - J Frank
- Division of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - V Frouin
- Neurospin, Commissariat à l'Energie Atomique et aux Energies Alternatives, Paris, France
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - H Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland; Department of Psychiatry, University of Vermont, USA; Department of Psychology, University of Vermont, USA
| | - P Gowland
- School of Physics and Astronomy, University of Nottingham, United Kingdom
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin, Germany
| | - B Ittermann
- Physikalisch-Technische Bundesanstalt, Berlin, Germany
| | - K Mann
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - J-L Martinot
- INSERM CEA Unit 1000 "Imaging & Psychiatry", Institut National de la Santé et de la Recherche Médicale, University Paris Sud, Orsay, France; AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France
| | - T Paus
- Rotman Research Institute, University of Toronto, Toronto, Canada; Montreal Neurological Institute, McGill University, QC, Canada
| | - Z Pausova
- The Hospital for Sick Children, Department of Physiology and Nutritional Sciences, University of Toronto, Toronto, Canada
| | - T W Robbins
- Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, University of Cambridge, United Kingdom
| | - M N Smolka
- Department of Psychiatry and Psychotherapy, Neuroimaging Center, Technische Universitaet Dresden, Dresden, Germany
| | - M Rietschel
- Division of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - G Schumann
- Institute of Psychiatry, King's College London, United Kingdom; MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom
| | - H Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| |
Collapse
|
33
|
Desrivières S, Lourdusamy A, Tao C, Toro R, Jia T, Loth E, Medina LM, Kepa A, Fernandes A, Ruggeri B, Carvalho FM, Cocks G, Banaschewski T, Barker GJ, Bokde ALW, Büchel C, Conrod PJ, Flor H, Heinz A, Gallinat J, Garavan H, Gowland P, Brühl R, Lawrence C, Mann K, Martinot MLP, Nees F, Lathrop M, Poline JB, Rietschel M, Thompson P, Fauth-Bühler M, Smolka MN, Pausova Z, Paus T, Feng J, Schumann G. Single nucleotide polymorphism in the neuroplastin locus associates with cortical thickness and intellectual ability in adolescents. Mol Psychiatry 2015; 20:263-74. [PMID: 24514566 PMCID: PMC4051592 DOI: 10.1038/mp.2013.197] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2013] [Revised: 11/19/2013] [Accepted: 12/09/2013] [Indexed: 12/30/2022]
Abstract
Despite the recognition that cortical thickness is heritable and correlates with intellectual ability in children and adolescents, the genes contributing to individual differences in these traits remain unknown. We conducted a large-scale association study in 1583 adolescents to identify genes affecting cortical thickness. Single-nucleotide polymorphisms (SNPs; n=54,837) within genes whose expression changed between stages of growth and differentiation of a human neural stem cell line were selected for association analyses with average cortical thickness. We identified a variant, rs7171755, associating with thinner cortex in the left hemisphere (P=1.12 × 10(-)(7)), particularly in the frontal and temporal lobes. Localized effects of this SNP on cortical thickness differently affected verbal and nonverbal intellectual abilities. The rs7171755 polymorphism acted in cis to affect expression in the human brain of the synaptic cell adhesion glycoprotein-encoding gene NPTN. We also found that cortical thickness and NPTN expression were on average higher in the right hemisphere, suggesting that asymmetric NPTN expression may render the left hemisphere more sensitive to the effects of NPTN mutations, accounting for the lateralized effect of rs7171755 found in our study. Altogether, our findings support a potential role for regional synaptic dysfunctions in forms of intellectual deficits.
Collapse
Affiliation(s)
- S Desrivières
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, 16 De Crespigny Park, Denmark Hill, London SE5 8AF, UK. E-mail:
| | - A Lourdusamy
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - C Tao
- Center for Computational Systems Biology, Fudan University, Shanghai, China
| | - R Toro
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France,CNRS URA 2182, Genes, synapses and cognition, Institut Pasteur, Paris, France
| | - T Jia
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - E Loth
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - L M Medina
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - A Kepa
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - A Fernandes
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - B Ruggeri
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - F M Carvalho
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | - G Cocks
- Institute of Psychiatry, King's College, London, UK
| | - T Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany,Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany
| | - G J Barker
- Institute of Psychiatry, King's College, London, UK
| | - A L W Bokde
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
| | - C Büchel
- Department of Systems Neuroscience, Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
| | - P J Conrod
- Institute of Psychiatry, King's College, London, UK,Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montreal, QC, Canada
| | - H Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité—Universitätsmedizin, Berlin, Germany
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité—Universitätsmedizin, Berlin, Germany
| | - H Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland,Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - P Gowland
- Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - R Brühl
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany
| | - C Lawrence
- School of Psychology, University of Nottingham, Nottingham, UK
| | - K Mann
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
| | - M L P Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM CEA Unit 1000 ‘Imaging & Psychiatry', University Paris Sud, Orsay, France,AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France
| | - F Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - M Lathrop
- Centre National de Génotypage, Evry, France
| | - J-B Poline
- Neurospin, Commissariat àl'Energie Atomique et aux Energies Alternatives, Paris, France
| | - M Rietschel
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Mannheim, Germany
| | - P Thompson
- Imaging Genetics Center/Laborarory of Neuro Imaging, UCLA School of Medicine, Los Angeles, CA, USA
| | - M Fauth-Bühler
- Department of Addictive Behaviour and Addiction Medicine, Medical Faculty Mannheim, Central Institute of Mental Health, Heidelberg University, Mannheim, Germany
| | - M N Smolka
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany,Department of Psychology, Neuroimaging Center, Technische Universität Dresden, Dresden, Germany
| | - Z Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - T Paus
- School of Psychology, University of Nottingham, Nottingham, UK,Rotman Research Institute, University of Toronto, Toronto, ON, Canada,Montreal Neurological Institute, McGill University, Montreal, Canada
| | - J Feng
- Center for Computational Systems Biology, Fudan University, Shanghai, China,Department of Computer Science and Centre for Scientific Computing, Warwick University, Coventry, UK
| | - G Schumann
- Institute of Psychiatry, King's College, London, UK,MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, King's College London, London, UK
| | | |
Collapse
|
34
|
Castellanos-Ryan N, Struve M, Whelan R, Banaschewski T, Barker GJ, Bokde ALW, Bromberg U, Büchel C, Flor H, Fauth-Bühler M, Frouin V, Gallinat J, Gowland P, Heinz A, Lawrence C, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Schumann G, Garavan H, Conrod PJ. Neural and cognitive correlates of the common and specific variance across externalizing problems in young adolescence. Am J Psychiatry 2014; 171:1310-9. [PMID: 25073448 DOI: 10.1176/appi.ajp.2014.13111499] [Citation(s) in RCA: 93] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Longitudinal and family-based research suggests that conduct disorder, substance misuse, and ADHD involve both unique forms of dysfunction as well as more specific dysfunctions unique to each condition. Using direct measures of brain function, this study also found evidence in both unique and disorder-specific perturbations.
Collapse
Affiliation(s)
- Natalie Castellanos-Ryan
- From the Department of Psychiatry and the Department of Psychoeducation, University of Montreal, and CHU Sainte-Justine Hospital, Montreal; the Department of Clinical and Cognitive Neuroscience and the Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; the Departments of Psychiatry and Psychology, University of Vermont, Burlington; the Institute of Psychiatry, King's College London; the Institute of Neuroscience and Discipline of Psychiatry, School of Medicine, Trinity College Dublin; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Neurospin, Atomic Energy and Alternative Energies Commission, Paris; the Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin; the School of Psychology and the School of Physics and Astronomy, University of Nottingham, Nottingham, U.K.; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany; Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 1000, Imaging and Psychiatry, SHFJ CEA, University of Paris South, Orsay, France; AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris; Rotman Research Institute, University of Toronto, Toronto; Montreal Neurological Institute, McGill University, Montreal; Hospital for Sick Children, University of Toronto, Toronto; Behavioural and Clinical Neurosciences Institute, Department of Experimental Psychology, University of Cambridge, Cambridge, U.K.; the Department of Psychiatry and the Neuroimaging Center, Technische Universität Dresden, Germany; and MRC Social, Genetic, and Developmental Psychiatry (SGDP) Centre, London
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Stringaris A, Castellanos-Ryan N, Banaschewski T, Barker GJ, Bokde AL, Bromberg U, Büchel C, Fauth-Bühler M, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Itterman B, Lawrence C, Nees F, Paillere-Martinot ML, Paus T, Pausova Z, Rietschel M, Smolka MN, Schumann G, Goodman R, Conrod P. Dimensions of manic symptoms in youth: psychosocial impairment and cognitive performance in the IMAGEN sample. J Child Psychol Psychiatry 2014; 55:1380-9. [PMID: 24865127 PMCID: PMC4167034 DOI: 10.1111/jcpp.12255] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 03/25/2014] [Indexed: 11/28/2022]
Abstract
BACKGROUND It has been reported that mania may be associated with superior cognitive performance. In this study, we test the hypothesis that manic symptoms in youth separate along two correlated dimensions and that a symptom constellation of high energy and cheerfulness is associated with superior cognitive performance. METHOD We studied 1755 participants of the IMAGEN study, of average age 14.4 years (SD = 0.43), 50.7% girls. Manic symptoms were assessed using the Development and Wellbeing Assessment by interviewing parents and young people. Cognition was assessed using the Wechsler Intelligence Scale For Children (WISC-IV) and a response inhibition task. RESULTS Manic symptoms in youth formed two correlated dimensions: one termed exuberance, characterized by high energy and cheerfulness and one of undercontrol with distractibility, irritability and risk-taking behavior. Only the undercontrol, but not the exuberant dimension, was independently associated with measures of psychosocial impairment. In multivariate regression models, the exuberant, but not the undercontrolled, dimension was positively and significantly associated with verbal IQ by both parent- and self-report; conversely, the undercontrolled, but not the exuberant, dimension was associated with poor performance in a response inhibition task. CONCLUSIONS Our findings suggest that manic symptoms in youth may form dimensions with distinct correlates. The results are in keeping with previous findings about superior performance associated with mania. Further research is required to study etiological differences between these symptom dimensions and their implications for clinical practice.
Collapse
Affiliation(s)
| | - Natalie Castellanos-Ryan
- Department of Psychiatry, Centre de recherche du CHU Ste-Justine, Montral UniversityMontreal, QC, Canada
| | - Tobias Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthMannheim, Germany,Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of HeidelbergMannheim, Germany
| | | | - Arun L Bokde
- Institute of Neuroscience, School of Medicine, Trinity College DublinDublin, Ireland
| | - Uli Bromberg
- University Medical Centre Hamburg-EppendorfHamburg, Germany
| | | | - Mira Fauth-Bühler
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthMannheim, Germany
| | - Herta Flor
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthMannheim, Germany,Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of HeidelbergMannheim, Germany
| | | | - Juergen Gallinat
- Department of Psychiatry and Psychology, Campus Charite Mitte, Charite Universitatsmedizin BerlinBerlin, Germany
| | - Hugh Garavan
- Institute of Neuroscience, School of Medicine, Trinity College DublinDublin, Ireland,Department of Psychiatry and Psychology, University of VermontBurlington, VT, USA
| | - Penny Gowland
- School of Physics and Astronomy, University of NottinghamNottingham, UK
| | - Andreas Heinz
- Department of Psychiatry and Psychology, Campus Charite Mitte, Charite Universitatsmedizin BerlinBerlin, Germany
| | - Bernd Itterman
- Physikalisch-Technische Bundesanstalt (PTB)Berlin, Germany
| | - Claire Lawrence
- School of Psychology, University of NottinghamNottingham, UK
| | - Frauke Nees
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthMannheim, Germany,Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of HeidelbergMannheim, Germany
| | - Marie-Laure Paillere-Martinot
- Institut National de la Sante et de la Recherche Medicale, INSERM CEA Unit 1000 Imaging & Psychiatry, University Paris SudOrsay, France
| | - Tomas Paus
- School of Psychology, University of NottinghamNottingham, UK,Rotman Research Institute, University of TorontoToronto, ON, Canada,Montreal Neurological Institute, McGill UniversityMontreal, QC, Canada
| | - Zdenka Pausova
- The Hospital for Sick Children, University of TorontoToronto, ON, Canada
| | - Marcella Rietschel
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental HealthMannheim, Germany,Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, University of HeidelbergMannheim, Germany,Department of Genetic Epidemiology, Central Institute of Mental Health, Medical Faculty Mannheim, University of HeidelbergMannheim, Germany
| | - Michael N Smolka
- Neuroimaging Centre, Department of Psychiatry and Psychotherapy, Dresden University of TechnologyDresden, Germany
| | | | - Robert Goodman
- Institute of Psychiatry, King's College LondonLondon, UK
| | | | | |
Collapse
|
36
|
Dickie EW, Tahmasebi A, French L, Kovacevic N, Banaschewski T, Barker GJ, Bokde A, Büchel C, Conrod P, Flor H, Garavan H, Gallinat J, Gowland P, Heinz A, Ittermann B, Lawrence C, Mann K, Martinot JL, Nees F, Nichols T, Lathrop M, Loth E, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Toro R, Schumann G, Paus T. Global genetic variations predict brain response to faces. PLoS Genet 2014; 10:e1004523. [PMID: 25122193 PMCID: PMC4133042 DOI: 10.1371/journal.pgen.1004523] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2013] [Accepted: 05/30/2014] [Indexed: 01/21/2023] Open
Abstract
Face expressions are a rich source of social signals. Here we estimated the proportion of phenotypic variance in the brain response to facial expressions explained by common genetic variance captured by ∼500,000 single nucleotide polymorphisms. Using genomic-relationship-matrix restricted maximum likelihood (GREML), we related this global genetic variance to that in the brain response to facial expressions, as assessed with functional magnetic resonance imaging (fMRI) in a community-based sample of adolescents (n = 1,620). Brain response to facial expressions was measured in 25 regions constituting a face network, as defined previously. In 9 out of these 25 regions, common genetic variance explained a significant proportion of phenotypic variance (40–50%) in their response to ambiguous facial expressions; this was not the case for angry facial expressions. Across the network, the strength of the genotype-phenotype relationship varied as a function of the inter-individual variability in the number of functional connections possessed by a given region (R2 = 0.38, p<0.001). Furthermore, this variability showed an inverted U relationship with both the number of observed connections (R2 = 0.48, p<0.001) and the magnitude of brain response (R2 = 0.32, p<0.001). Thus, a significant proportion of the brain response to facial expressions is predicted by common genetic variance in a subset of regions constituting the face network. These regions show the highest inter-individual variability in the number of connections with other network nodes, suggesting that the genetic model captures variations across the adolescent brains in co-opting these regions into the face network. We measured brain response to facial expressions in a large sample of typically developing adolescents (n = 1,620) and assessed “heritability” of the response using common genetic variations across the genome. In a subset of brain regions, we explained 40–50% of phenotypic variance by genetic variance. These brain regions appear to differ from the rest of the face network in the degree of inter-individual variations in their functional connectivity. We propose that these regions, including the prefrontal and premotor cortex, represent “Optional” part of the network co-opted by its “Obligatory” members, including the posterior part of the superior temporal sulcus, fusiform face area and the lateral occipital cortex, concerned with processing complex visual stimuli.
Collapse
Affiliation(s)
- Erin W. Dickie
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Amir Tahmasebi
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
- Philips Research North America, Briarcliff Manor, New York, United States of America
| | - Leon French
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Natasa Kovacevic
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
| | - Tobias Banaschewski
- Central Institute of Mental Health, Mannheim, Germany
- Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Gareth J. Barker
- Institute of Psychiatry, King's College London, London, United Kingdom
| | - Arun Bokde
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
| | | | - Patricia Conrod
- Institute of Psychiatry, King's College London, London, United Kingdom
- Department of Psychiatry, Universite de Montreal, CHU Ste Justine Hospital, Montreal, Quebec, Canada
| | - Herta Flor
- Central Institute of Mental Health, Mannheim, Germany
- Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Hugh Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland
- Departments of Psychiatry and Psychology, University of Vermont, Burlington, Vermont, United States of America
| | - Juergen Gallinat
- Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Penny Gowland
- Sir Peter Mansfield MR Centre, University of Nottingham, Nottingham, United Kindom
| | - Andreas Heinz
- Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | - Bernd Ittermann
- Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany
| | - Claire Lawrence
- School of Psychology, University of Nottingham, Nottingham, United Kindom
| | - Karl Mann
- Central Institute of Mental Health, Mannheim, Germany
- Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Jean-Luc Martinot
- Institut National de la Santé et de la Recherche Médicale, INSERM CEA Unit 1000 “Imaging & Psychiatry”, University Paris Sud, Orsay, and AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France
| | - Frauke Nees
- Central Institute of Mental Health, Mannheim, Germany
- Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | | | | | - Eva Loth
- Institute of Psychiatry, King's College London, London, United Kingdom
- MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom
| | - Zdenka Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
| | - Marcela Rietschel
- Central Institute of Mental Health, Mannheim, Germany
- Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
| | - Michal N. Smolka
- Department of Psychiatry and Psychotherapy, Technische Universität Dresden, Dresden, Germany
- Neuroimaging Center, Department of Psychology, Technische Universität Dresden, Dresden, Germany
| | - Andreas Ströhle
- Department of Psychiatry and Psychotherapy, Charité – Universitätsmedizin Berlin, Berlin, Germany
| | | | - Gunter Schumann
- Institute of Psychiatry, King's College London, London, United Kingdom
- MRC Social, Genetic and Developmental Psychiatry (SGDP) Centre, London, United Kingdom
| | | | - Tomáš Paus
- Rotman Research Institute, University of Toronto, Toronto, Ontario, Canada
- School of Psychology, University of Nottingham, Nottingham, United Kindom
- * E-mail:
| |
Collapse
|
37
|
Kühn S, Gallinat J. Amount of lifetime video gaming is positively associated with entorhinal, hippocampal and occipital volume. Mol Psychiatry 2014; 19:842-7. [PMID: 23958958 DOI: 10.1038/mp.2013.100] [Citation(s) in RCA: 75] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2013] [Revised: 05/09/2013] [Accepted: 06/24/2013] [Indexed: 01/27/2023]
Abstract
Playing video games is a popular leisure activity among children and adults, and may therefore potentially influence brain structure. We have previously shown a positive association between probability of gray matter (GM) volume in the ventral striatum and frequent video gaming in adolescence. Here we set out to investigate structural correlates of video gaming in adulthood, as the effects observed in adolescents may reflect only a fraction of the potential neural long-term effects seen in adults. On magnetic resonance imaging (MRI) scans of 62 male adults, we computed voxel-based morphometry to explore the correlation of GM with the lifetime amount of video gaming (termed joystick years). We found a significant positive association between GM in bilateral parahippocamal region (entorhinal cortex) and left occipital cortex/inferior parietal lobe and joystick years (P<0.001, corrected for multiple comparisons). An exploratory analysis showed that the entorhinal GM volume can be predicted by the video game genres played, such as logic/puzzle games and platform games contributing positively, and action-based role-playing games contributing negatively. Furthermore, joystick years were positively correlated with hippocampus volume. The association of lifetime amount of video game playing with bilateral entorhinal cortex, hippocampal and occipital GM volume could reflect adaptive neural plasticity related to navigation and visual attention.
Collapse
Affiliation(s)
- S Kühn
- Max Planck Institute for Human Development, Center for Lifespan Psychology, Berlin, Germany
| | - J Gallinat
- Charité University Medicine, St Hedwig-Krankenhaus, Clinic for Psychiatry and Psychotherapy, Berlin, Germany
| |
Collapse
|
38
|
Balz J, Roa Romero Y, Keil J, Pomper U, Gallinat J, Senkowski D. P331: Neurophysiological markers of multisensory processing in schizophrenia. Clin Neurophysiol 2014. [DOI: 10.1016/s1388-2457(14)50449-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
39
|
Nymberg C, Jia T, Lubbe S, Ruggeri B, Desrivieres S, Barker G, Büchel C, Fauth-Buehler M, Cattrell A, Conrod P, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Lawrence C, Mann K, Nees F, Salatino-Oliveira A, Paillère Martinot ML, Paus T, Rietschel M, Robbins T, Smolka M, Banaschewski T, Rubia K, Loth E, Schumann G. Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype. Biol Psychiatry 2013; 74:607-14. [PMID: 23746540 DOI: 10.1016/j.biopsych.2013.03.027] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/17/2012] [Revised: 03/19/2013] [Accepted: 03/19/2013] [Indexed: 11/20/2022]
Abstract
BACKGROUND Attention-deficit/hyperactivity disorder (ADHD) is characterized by deficits in reward sensitivity and response inhibition. The relative contribution of these frontostriatal mechanisms to ADHD symptoms and their genetic determinants is largely unexplored. METHODS Using functional magnetic resonance imaging and genetic analysis of the monoamine oxidase A (MAOA) gene, we investigated how striatal and inferior frontal activation patterns contribute to ADHD symptoms depending on MAOA genotype in a sample of adolescent boys (n = 190). RESULTS We demonstrate an association of ADHD symptoms with distinct blood oxygen level-dependent (BOLD) responses depending on MAOA genotype. In A hemizygotes of the expression single nucleotide polymorphism rs12843268, which express lower levels of MAOA, ADHD symptoms are associated with lower ventral striatal BOLD response during the monetary incentive delay task and lower inferior frontal gyrus BOLD response during the stop signal task. In G hemizygotes, ADHD symptoms are associated with increased inferior frontal gyrus BOLD response during the stop signal task in the presence of increased ventral striatal BOLD response during the monetary incentive delay task. CONCLUSIONS Depending on MAOA genotype, ADHD symptoms in adolescent boys are associated with either reward deficiency or insufficient response inhibition. Apart from its mechanistic interest, our finding may aid in developing pharmacogenetic markers for ADHD.
Collapse
Affiliation(s)
- Charlotte Nymberg
- Medical Research Council-Social, Genetic and Developmental Psychiatry Centre (CN, TJ, SL, BR, SD, GB, AC, PC, EL, GS), Institute of Psychiatry, King's College London, London, United Kingdom.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Nees F, Witt SH, Lourdusamy A, Vollstädt-Klein S, Steiner S, Poustka L, Banaschewski T, Barker GJ, Büchel C, Conrod PJ, Frank J, Gallinat J, Garavan H, Heinz A, Ittermann B, Loth E, Mann K, Artiges E, Paus T, Pausova Z, Smolka MN, Struve M, Schumann G, Rietschel M, Flor H. Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents. Neuropsychopharmacology 2013; 38:2081-9. [PMID: 23689675 PMCID: PMC3773681 DOI: 10.1038/npp.2013.131] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/19/2012] [Revised: 04/23/2013] [Accepted: 04/25/2013] [Indexed: 01/30/2023]
Abstract
Genetic variation in a genomic region on chromosome 15q25.1, which encodes the alpha5, alpha3, and beta4 subunits of the cholinergic nicotinic receptor genes, confers risk to smoking and nicotine dependence (ND). Neural reward-related responses have previously been identified as important factors in the development of drug dependence involving ND. Applying an imaging genetics approach in two cohorts (N=487; N=478) of healthy non-smoking adolescents, we aimed to elucidate the impact of genome-wide significant smoking-associated variants in the CHRNA5-CHRNA3-CHRNB4 gene cluster on reward-related neural responses in central regions such as the striatum, orbitofrontal and anterior cingulate cortex (ACC), and personality traits related to addiction. In both samples, carriers of the rs578776 GG compared with AG/AA genotype showed a significantly lower neural response to reward outcomes in the right ventral and dorsal ACC but not the striatum or the orbitofrontal cortex. Rs578776 was unrelated to neural reward anticipation or reward magnitude. Significantly higher scores of anxiety sensitivity in GG compared with AG/AA carriers were found only in sample 1. Associations with other personality traits were not observed. Our findings suggest that the rs578776 risk variant influences susceptibility to ND by dampening the response of the ACC to reward feedback, without recruiting the striatum or orbitofrontal cortex during feedback or anticipation. Thus, it seems to have a major role in the processing of and behavioral adaptation to changing reward outcomes.
Collapse
Affiliation(s)
- F Nees
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany,Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, J 5, D-68159 Mannheim, Germany, Tel: +49 621 1703 6306, Fax: +49 621 1703 6305, E-mail:
| | - S H Witt
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - A Lourdusamy
- Institute of Psychiatry, King's College, London, UK
| | - S Vollstädt-Klein
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany
| | - S Steiner
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty, Heidelberg University, Mannheim, Germany
| | - L Poustka
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty, Heidelberg University, Mannheim, Germany
| | - T Banaschewski
- Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty, Heidelberg University, Mannheim, Germany
| | - G J Barker
- Institute of Psychiatry, King's College, London, UK
| | - C Büchel
- NeuroImage Nord, Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - P J Conrod
- Institute of Psychiatry, King's College, London, UK,Department of Psychiatry, Université de Montreal, CHU Ste Justine Hospital, Montréal, QC, Canada
| | - J Frank
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - J Gallinat
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité—Universitätsmedizin Berlin, Berlin, Germany
| | - H Garavan
- Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland,Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA
| | - A Heinz
- Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité—Universitätsmedizin Berlin, Berlin, Germany
| | - B Ittermann
- Physikalisch-Technische Bundesanstalt, Berlin, Germany
| | - E Loth
- Institute of Psychiatry, King's College, London, UK
| | - K Mann
- Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health, Mannheim, Germany
| | - E Artiges
- INSERM CEA Unit 1000 ‘Imaging & Psychiatry', Institut National de la Santé et de la Recherche Médicale, University Paris Sud, Orsay, and AP-HP Department of Adolescent Psychopathology and Medicine, Maison de Solenn, University Paris Descartes, Paris, France
| | - T Paus
- Rotman Research Institute, University of Toronto, Toronto, ON, Canada,School of Psychology, University of Nottingham, Nottingham, UK,Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Z Pausova
- The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
| | - M N Smolka
- Neuroimaging Center and Department of Psychiatry, Technische Universität Dresden, Dresden, Germany
| | - M Struve
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - G Schumann
- Institute of Psychiatry, King's College, London, UK
| | - M Rietschel
- Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | - H Flor
- Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
| | | |
Collapse
|
41
|
Lee NC, Krabbendam L, White TP, Meeter M, Banaschewski T, Barker GJ, Bokde ALW, Büchel C, Conrod P, Flor H, Frouin V, Heinz A, Garavan H, Gowland P, Ittermann B, Mann K, Paillère Martinot ML, Nees F, Paus T, Pausova Z, Rietschel M, Robbins T, Fauth-Bühler M, Smolka MN, Gallinat J, Schumann G, Shergill SS. Do you see what I see? Sex differences in the discrimination of facial emotions during adolescence. ACTA ACUST UNITED AC 2013; 13:1030-40. [PMID: 23914763 DOI: 10.1037/a0033560] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
During adolescence social relationships become increasingly important. Establishing and maintaining these relationships requires understanding of emotional stimuli, such as facial emotions. A failure to adequately interpret emotional facial expressions has previously been associated with various mental disorders that emerge during adolescence. The current study examined sex differences in emotional face processing during adolescence. Participants were adolescents (n = 1951) with a target age of 14, who completed a forced-choice emotion discrimination task. The stimuli used comprised morphed faces that contained a blend of two emotions in varying intensities (11 stimuli per set of emotions). Adolescent girls showed faster and more sensitive perception of facial emotions than boys. However, both adolescent boys and girls were most sensitive to variations in emotion intensity in faces combining happiness and sadness, and least sensitive to changes in faces comprising fear and anger. Furthermore, both sexes overidentified happiness and anger. However, the overidentification of happiness was stronger in boys. These findings were not influenced by individual differences in the level of pubertal maturation. These results indicate that male and female adolescents differ in their ability to identify emotions in morphed faces containing emotional blends. The findings provide information for clinical studies examining whether sex differences in emotional processing are related to sex differences in the prevalence of psychiatric disorders within this age group.
Collapse
|
42
|
Vulser H, Paillere-Martinot ML, Lemaitre H, Miranda R, Artiges E, Goodman R, Penttilä J, Struve M, Fadai T, Kappel V, Poustka L, Conrod P, Banaschewski T, Barbot A, Barker G, Büchel C, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Lawrence C, Loth E, Mann K, Paus T, Pausova Z, Rietschel M, Robbins T, Smolka M, Schumann G, Martinot JL. 2177 – Neuroanatomical changes associated with subthreshold depression in adolescents. Eur Psychiatry 2013. [DOI: 10.1016/s0924-9338(13)77052-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
43
|
Wirth C, Schubert F, Lautenschlager M, Brühl R, Klär A, Majic T, Lang UE, Ehrlich A, Winterer G, Sander T, Schouler-Ocak M, Gallinat J. DTNBP1 (dysbindin) gene variants: in vivo evidence for effects on hippocampal glutamate status. Curr Pharm Biotechnol 2012; 13:1513-21. [PMID: 22283763 DOI: 10.2174/138920112800784952] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2010] [Revised: 12/12/2010] [Accepted: 02/15/2011] [Indexed: 11/22/2022]
Abstract
INTRODUCTION In linkage and association studies the DTNBP1 gene has been identified as a major susceptibility gene for schizophrenia. Reduced expression of DTNBP1 was found in the hippocampus and prefrontal cortex in post mortem brains of schizophrenic patients. In vitro and animal models provide evidence that the DTNBP1 gene product dysbindin modulates the activity of the neurotransmitter glutamate in hippocampal neurons and is crucial for cell functioning and synaptogenesis. This study is the first to investigate the effects of genetic variants of DTNBP1 on the status of the glutamate system as well as neuronal integrity (N-acetylaspartate, NAA) in the hippocampus and a cortical region, the anterior cingulate cortex (ACC), in humans. METHODS In 79 healthy subjects, the association of single nucleotide polymorphisms (SNPs) rs760665 and rs909706 with absolute concentrations of glutamate and NAA in the left hippocampus and the ACC were investigated, using proton magnetic resonance spectroscopy (MRS) at 3 Tesla and a well established quantification procedure. RESULTS Hippocampal glutamate concentration was significantly affected by genotype of rs760665 (F=4.406, df=2,p=0.016) and rs909706 (F=3.171,df=2,p=0.048). For the concentration of NAA, a weak association with rs760665 was observed in the contrast analysis. None of the metabolites measured in the ACC showed a significant connection with either genotype. CONCLUSION The results support a role of DTNBP1 gene variants in the glutamate neurotransmission system in the human brain at least in the hippocampus. This is compatible to growing evidence of a crucial role of glutamate in the pathobiology of schizophrenia. In addition, the weak association between DTNBP1 genotype and NAA is in line with a regulatory influence of dysbindin on synaptogenesis and neuronal survival.
Collapse
Affiliation(s)
- C Wirth
- Charite University Medicine Berlin, Campus Mitte, Clinic for Psychiatry and Psychotherapy, 10117 Berlin, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Schneider S, Brassen S, Bromberg U, Banaschewski T, Conrod P, Flor H, Gallinat J, Garavan H, Heinz A, Martinot JL, Nees F, Rietschel M, Smolka MN, Ströhle A, Struve M, Schumann G, Büchel C. Maternal interpersonal affiliation is associated with adolescents' brain structure and reward processing. Transl Psychiatry 2012; 2:e182. [PMID: 23149446 PMCID: PMC3565762 DOI: 10.1038/tp.2012.113] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2012] [Revised: 09/21/2012] [Accepted: 10/06/2012] [Indexed: 11/09/2022] Open
Abstract
Considerable animal and human research has been dedicated to the effects of parenting on structural brain development, focusing on hippocampal and prefrontal areas. Conversely, although functional imaging studies suggest that the neural reward circuitry is involved in parental affection, little is known about mothers' interpersonal qualities in relation to their children's brain structure and function. Moreover, gender differences concerning the effect of maternal qualities have rarely been investigated systematically. In 63 adolescents, we assessed structural and functional magnetic resonance imaging as well as interpersonal affiliation in their mothers. This allowed us to associate maternal affiliation with gray matter density and neural responses during different phases of the well-established Monetary Incentive Delay task. Maternal affiliation was positively associated with hippocampal and orbitofrontal gray matter density. Moreover, in the feedback of reward hit as compared with reward miss, an association with caudate activation was found. Although no significant gender effects were observed in these associations, during reward feedback as compared with baseline, maternal affiliation was significantly associated with ventral striatal and caudate activation only in females. Our findings demonstrate that maternal interpersonal affiliation is related to alterations in both the brain structure and reward-related activation in healthy adolescents. Importantly, the pattern is in line with typical findings in depression and post-traumatic stress disorder, suggesting that a lack of maternal affiliation might have a role in the genesis of mental disorders.
Collapse
Affiliation(s)
- S Schneider
- Department of Systems Neuroscience, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Kühn S, Musso F, Mobascher A, Warbrick T, Winterer G, Gallinat J. Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometry. Transl Psychiatry 2012; 2:e127. [PMID: 22692142 PMCID: PMC3384220 DOI: 10.1038/tp.2012.51] [Citation(s) in RCA: 69] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
Alterations of hippocampal anatomy have been reported consistently in schizophrenia. Within the present study, we used FreeSurfer to determine hippocampal subfield volumes in 21 schizophrenic patients. A negative correlation between PANSS-positive symptom score and bilateral hippocampal subfield CA2/3 as well as CA1 volume was found on high-resolution magnetic resonance images. Our observation opens the gate for advanced investigation of the commonly reported hippocampal abnormalities in schizophrenia in terms of specific subfields.
Collapse
Affiliation(s)
- S Kühn
- Charité University Medicine, St Hedwig-Krankenhaus, Clinic for Psychiatry and Psychotherapy, Berlin, Germany.
| | - F Musso
- Department of Psychiatry, University of Düsseldorf, Düsseldorf, Germany
| | - A Mobascher
- Department of Psychiatry, University of Mainz, Mainz, Germany,Institute of Neurosciences and Medicine, Helmholtz Research Centre Jülich, Jülich, Germany
| | - T Warbrick
- Institute of Neurosciences and Medicine, Helmholtz Research Centre Jülich, Jülich, Germany
| | - G Winterer
- Institute of Neurosciences and Medicine, Helmholtz Research Centre Jülich, Jülich, Germany,Cologne Center for Genomics, University of Cologne, Cologne, Germany
| | - J Gallinat
- Charité University Medicine, St Hedwig-Krankenhaus, Clinic for Psychiatry and Psychotherapy, Berlin, Germany
| |
Collapse
|
46
|
Gallinat J. AS23-03 - From genomics to pathobiology and personalized medicine - where do we stand in psychiatry. Eur Psychiatry 2012. [DOI: 10.1016/s0924-9338(12)74018-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
47
|
Hauser M, Knoblich G, Repp BH, Lautenschlager M, Gallinat J, Heinz A, Voss M. Altered sense of agency in schizophrenia and the putative psychotic prodrome. Psychiatry Res 2011; 186:170-6. [PMID: 20826001 DOI: 10.1016/j.psychres.2010.08.003] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/07/2009] [Revised: 06/04/2010] [Accepted: 08/10/2010] [Indexed: 01/12/2023]
Abstract
The mechanisms underlying distortions in sense of agency, i.e. the experience of controlling one's own actions and their consequences, in schizophrenia are not fully understood and have barely been investigated in patients classified as being in a putative psychotic prodrome. This study aims to expound the contribution of early and late illness-related processes. Thirty schizophrenia patients, 30 putatively prodromal patients and 30 healthy controls were instructed to reproduce a computer-generated series of drum sounds on a drum pad. While tapping, subjects heard either their self-produced tones or a computer-controlled reproduction of the drum tone series that used either exactly the same, an accelerated or decelerated tempo. Subjects had to determine the source of agency. Results show similar significant impairments in assigning the source of agency under ambiguous conditions in schizophrenia and putatively prodromal patients and an exaggerated self-attribution bias, both of which were significantly correlated with increased (ego-)psychopathology. Patient groups, however, benefited significantly more than controls from additional sensorimotor cues to agency. Sensorimotor input seems to be a compensatory mechanism involved in correctly attributing agency. We deduce that altered awareness of agency may hold promise as an additional risk factor for psychosis.
Collapse
Affiliation(s)
- Marta Hauser
- The Zucker Hillside Hospital, North Shore - Long Island Jewish Health System, Glen Oaks, NY, USA.
| | | | | | | | | | | | | |
Collapse
|
48
|
Hauser M, Moore JW, de Millas W, Gallinat J, Heinz A, Haggard P, Voss M. Sense of agency is altered in patients with a putative psychotic prodrome. Schizophr Res 2011; 126:20-7. [PMID: 21112189 DOI: 10.1016/j.schres.2010.10.031] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/25/2010] [Revised: 10/26/2010] [Accepted: 10/28/2010] [Indexed: 10/18/2022]
Abstract
BACKGROUND Sense of agency (SoAg)--the experience of controlling one's own actions and their consequences--has been studied in schizophrenia but not in the earlier stages of the disease, i.e. in patients with a putative psychotic prodrome (PP). Previous research has shown that time judgments of voluntary actions can provide an implicit measure of the SoAg. METHOD 30 PP patients and 30 healthy controls performed voluntary key presses while watching a rotating clock hand on a monitor. After each key press they had to estimate the time of the action (based on the perceived position of the clock hand at the time of the key press). By varying the probability with which the simple manual action was followed by a tone, we investigated whether shifts in perceptual estimates of the operant action towards a resulting effect depended on the actual occurrence of the effect (retrospective process) or on the prediction that the effect will occur. RESULTS PP patients differed from healthy controls but their results did not resemble previous findings in schizophrenia patients. PP patients showed numerically--but not significantly--stronger temporal linkage between action and consequence than healthy controls. Retrospective and predictive influences on action binding were stronger in PP patients. Furthermore, the altered influence of prediction was significantly correlated to ego-psychopathology. DISCUSSION Distortions of agency constitute a core feature of the disease that is already present in the PP but may evolve further with progression of the illness. Distortions of agency may thus represent a promising additional predictive risk factor for transition to psychosis in PP patients.
Collapse
Affiliation(s)
- Marta Hauser
- Department of Psychiatry and Psychotherapy, Charité University Medicine Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany.
| | | | | | | | | | | | | |
Collapse
|
49
|
Schneider S, Peters J, Bromberg U, Brassen S, Menz MM, Miedl SF, Loth E, Banaschewski T, Barbot A, Barker G, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Mallik C, Mann K, Artiges E, Paus T, Poline JB, Rietschel M, Reed L, Smolka MN, Spanagel R, Speiser C, Ströhle A, Struve M, Schumann G, Büchel C. Boys do it the right way: sex-dependent amygdala lateralization during face processing in adolescents. Neuroimage 2011; 56:1847-53. [PMID: 21316467 DOI: 10.1016/j.neuroimage.2011.02.019] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2010] [Revised: 02/03/2011] [Accepted: 02/04/2011] [Indexed: 11/25/2022] Open
Abstract
Previous studies have observed a sex-dependent lateralization of amygdala activation related to emotional memory. Specifically, it was shown that the activity of the right amygdala correlates significantly stronger with memory for images judged as arousing in men than in women, and that there is a significantly stronger relationship in women than in men between activity of the left amygdala and memory for arousing images. Using a large sample of 235 male adolescents and 235 females matched for age and handedness, we investigated the sex-specific lateralization of amygdala activation during an emotional face perception fMRI task. Performing a formal sex by hemisphere analysis, we observed in males a significantly stronger right amygdala activation as compared to females. Our results indicate that adolescents display a sex-dependent lateralization of amygdala activation that is also present in basic processes of emotional perception. This finding suggests a sex-dependent development of human emotion processing and may further implicate possible etiological pathways for mental disorders most frequent in adolescent males (i.e., conduct disorder).
Collapse
Affiliation(s)
- S Schneider
- NeuroimageNord, Department of Systems Neuroscience, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Schumann G, Loth E, Banaschewski T, Barbot A, Barker G, Büchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Itterman B, Lathrop M, Mallik C, Mann K, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Reed L, Smolka M, Spanagel R, Speiser C, Stephens DN, Ströhle A, Struve M. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 2010; 15:1128-39. [PMID: 21102431 DOI: 10.1038/mp.2010.4] [Citation(s) in RCA: 429] [Impact Index Per Article: 30.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
A fundamental function of the brain is to evaluate the emotional and motivational significance of stimuli and to adapt behaviour accordingly. The IMAGEN study is the first multicentre genetic-neuroimaging study aimed at identifying the genetic and neurobiological basis of individual variability in impulsivity, reinforcer sensitivity and emotional reactivity, and determining their predictive value for the development of frequent psychiatric disorders. Comprehensive behavioural and neuropsychological characterization, functional and structural neuroimaging and genome-wide association analyses of 2000 14-year-old adolescents are combined with functional genetics in animal and human models. Results will be validated in 1000 adolescents from the Canadian Saguenay Youth Study. The sample will be followed up longitudinally at the age of 16 years to investigate the predictive value of genetics and intermediate phenotypes for the development of frequent psychiatric disorders. This review describes the strategies the IMAGEN consortium used to meet the challenges posed by large-scale multicentre imaging-genomics investigations. We provide detailed methods and Standard Operating Procedures that we hope will be helpful for the design of future studies. These include standardization of the clinical, psychometric and neuroimaging-acquisition protocols, development of a central database for efficient analyses of large multimodal data sets and new analytic approaches to large-scale genetic neuroimaging analyses.
Collapse
Affiliation(s)
- G Schumann
- King's College London, MRC Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, London, UK.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|